drug_name listlengths 1 3 | alias listlengths 1 56 ⌀ | target listlengths 1 17 | disease listlengths 1 620 | drug_type listlengths 1 3 | global_highest_dev_status stringclasses 16
values | first_approved_date int64 -872,726,400,000 1,777B | first_approved_indication listlengths 1 21 | approval_country listlengths 1 37 |
|---|---|---|---|---|---|---|---|---|
[
{
"name": "卡替拉韦钠",
"lang": "CN"
},
{
"name": "Cabotegravir sodium",
"lang": "EN"
},
{
"name": "カボテグラビル",
"lang": "JP"
}
] | [
{
"name": "744 LA Injection",
"lang": "EN"
},
{
"name": "CAB LA - ViiV Healthcare",
"lang": "EN"
},
{
"name": "卡博特格韦",
"lang": "CN"
},
{
"name": "卡博特韦",
"lang": "CN"
},
{
"name": "卡博特韦钠",
"lang": "CN"
}
] | [
[
{
"name": "HIV integrase",
"lang": "EN"
},
{
"name": "HIV整合酶",
"lang": "CN"
}
]
] | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
],
[
{
"name": "Hepatitis",
"lang": "EN"
},
{
"name": "肝炎",
"lang": "CN"
}
],
[
{
"name": "Herpesviridae Infections",
"lang": "EN"
... | [
"Small molecule drug"
] | Pending | 1,600,646,400,000 | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"United Kingdom",
"Canada",
"Australia",
"Brazil",
"Iceland",
"Liechtenstein",
"Norway",
"South Africa",
"Zimbabwe"
] |
[
{
"name": "Ocrelizumab/Hyaluronidase-ocsq",
"lang": "EN"
}
] | [
{
"name": "Ocrelizumab & Hyaluronidase",
"lang": "EN"
},
{
"name": "Ocrelizumab/Hyaluronidase",
"lang": "EN"
},
{
"name": "Ocrelizumab/Hyaluronidase-OCSQ",
"lang": "EN"
}
] | [
[
{
"name": "Hyaluronic acid",
"lang": "EN"
},
{
"name": "透明质酸",
"lang": "CN"
}
]
] | [
[
{
"name": "Multiple Sclerosis, Secondary Progressive",
"lang": "EN"
},
{
"name": "继发进展型多发性硬化",
"lang": "CN"
}
],
[
{
"name": "Multiple sclerosis relapse",
"lang": "EN"
},
{
"name": "复发性多发性硬化",
"lang": "CN"
}
],
[
{
"... | [
"Monoclonal antibody",
"Enzyme"
] | Approved | 1,719,210,191,259 | [
[
{
"name": "Multiple sclerosis relapse",
"lang": "EN"
},
{
"name": "复发性多发性硬化",
"lang": "CN"
}
],
[
{
"name": "Multiple Sclerosis, Primary Progressive",
"lang": "EN"
},
{
"name": "原发性进行性多发性硬化",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "克拉生坦",
"lang": "CN"
},
{
"name": "Clazosentan sodium",
"lang": "EN"
},
{
"name": "クラゾセンタンナトリウム",
"lang": "JP"
}
] | null | [
[
{
"name": "Endothelin receptor type A",
"lang": "EN"
},
{
"name": "内皮素A受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Brain Ischemia",
"lang": "EN"
},
{
"name": "脑缺血",
"lang": "CN"
}
],
[
{
"name": "Subarachnoid Hemorrhage",
"lang": "EN"
},
{
"name": "蛛网膜下腔出血",
"lang": "CN"
}
],
[
{
"name": "Vasospasm, Intracranial",
... | [
"Small molecule drug"
] | Pending | 1,642,636,800,000 | [
[
{
"name": "Subarachnoid Hemorrhage",
"lang": "EN"
},
{
"name": "蛛网膜下腔出血",
"lang": "CN"
}
]
] | [
"Japan",
"South Korea"
] |
[
{
"name": "利巴韦林",
"lang": "CN"
},
{
"name": "Ribavirin",
"lang": "EN"
},
{
"name": "リバビリン",
"lang": "JP"
}
] | [
{
"name": "1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide",
"lang": "EN"
},
{
"name": "1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide",
"lang": "EN"
},
{
"name": "Pegasys RBV",
"lang": "EN"
},
{
"name": "RBV",
"lang": "EN"
},
{
"name": "Ribabirin",
... | [
[
{
"name": "Inosine-5'-monophosphate dehydrogenase (IMPDH)",
"lang": "EN"
},
{
"name": "肌苷-5 '-磷酸脱氢酶（IMPDH）家族",
"lang": "CN"
}
],
[
{
"name": "Bacterial DNA-directed RNA polymerase",
"lang": "EN"
},
{
"name": "细菌DNA指导的RNA聚合酶复合体",
"lang... | [
[
{
"name": "Compensated cirrhosis",
"lang": "EN"
},
{
"name": "代偿期肝硬化",
"lang": "CN"
}
],
[
{
"name": "Hepatitis C",
"lang": "EN"
},
{
"name": "丙型肝炎",
"lang": "CN"
}
],
[
{
"name": "Hepatitis C, Chronic",
"lang"... | [
"Small molecule drug"
] | Pending | 504,835,200,000 | [
[
{
"name": "Respiratory Syncytial Virus Infections",
"lang": "EN"
},
{
"name": "呼吸道合胞体病毒感染",
"lang": "CN"
}
]
] | [
"China",
"Japan",
"Australia",
"South Korea"
] |
[
{
"name": "聚乙二醇干扰素α-2b注射(Merck & Co)",
"lang": "CN"
},
{
"name": "Peginterferon alfa-2b(Merck & Co)",
"lang": "EN"
}
] | [
{
"name": "PEG-IFN-alfa2b",
"lang": "EN"
},
{
"name": "PegIntron Sterile Powder",
"lang": "EN"
},
{
"name": "Peginterferon alfa-2b (Merck Sharp & Dohme)",
"lang": "EN"
},
{
"name": "Pegintron Powder",
"lang": "EN"
},
{
"name": "peginterferon alfa-2b",
"lang": ... | [
[
{
"name": "Type I IFN Receptor",
"lang": "EN"
},
{
"name": "I型干扰素受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Melanoma",
"lang": "EN"
},
{
"name": "黑色素瘤",
"lang": "CN"
}
],
[
{
"name": "Hepatitis B",
"lang": "EN"
},
{
"name": "乙型肝炎",
"lang": "CN"
}
],
[
{
"name": "Hepatitis C",
"lang": "EN"
},
{
... | [
"Interferons"
] | Discontinued | 959,126,400,000 | [
[
{
"name": "Hepatitis C, Chronic",
"lang": "EN"
},
{
"name": "慢性丙型肝炎",
"lang": "CN"
}
]
] | [
"United States",
"China",
"Japan",
"Taiwan Province"
] |
[
{
"name": "利福布汀",
"lang": "CN"
},
{
"name": "Rifabutin",
"lang": "EN"
},
{
"name": "リファブチン",
"lang": "JP"
}
] | [
{
"name": "1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin XIV",
"lang": "EN"
},
{
"name": "4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S",
"lang": "EN"
},
{
"name": "4-N-isobutylspiropiperidylrifamycin S",
"lang": "EN"
},
... | [
[
{
"name": "Bacterial DNA-directed RNA polymerase",
"lang": "EN"
},
{
"name": "细菌DNA指导的RNA聚合酶复合体",
"lang": "CN"
}
]
] | [
[
{
"name": "Mycobacterium Avium-Intracellulare Infection",
"lang": "EN"
},
{
"name": "细胞内鸟分枝杆菌感染",
"lang": "CN"
}
],
[
{
"name": "Tuberculosis, Multidrug-Resistant",
"lang": "EN"
},
{
"name": "耐多药结核病",
"lang": "CN"
}
],
[
{... | [
"Small molecule drug"
] | Phase 1 Clinical | 725,068,800,000 | [
[
{
"name": "Mycobacterium Infections, Nontuberculous",
"lang": "EN"
},
{
"name": "非结核分枝杆菌感染",
"lang": "CN"
}
]
] | [
"United States",
"China",
"Japan"
] |
[
{
"name": "盐酸维那卡兰",
"lang": "CN"
},
{
"name": "Vernakalant Hydrochloride",
"lang": "EN"
}
] | [
{
"name": "(3R)-1-((1R,2R)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)pyrrolidin-3-ol",
"lang": "EN"
},
{
"name": "Brinavess",
"lang": "EN"
},
{
"name": "Kynapid",
"lang": "EN"
},
{
"name": "Vernakalant",
"lang": "EN"
},
{
"name": "Vernakalant hydrochloride (USAN... | [
[
{
"name": "Voltage-gated potassium channel subunit Kv1.5",
"lang": "EN"
},
{
"name": "电压门控性钾通道蛋白亚型Kv1.5",
"lang": "CN"
}
],
[
{
"name": "Voltage-gated sodium channels",
"lang": "EN"
},
{
"name": "电压门控钠离子通道",
"lang": "CN"
}
],
... | [
[
{
"name": "Atrial Fibrillation",
"lang": "EN"
},
{
"name": "心房颤动",
"lang": "CN"
}
],
[
{
"name": "Arrhythmias, Cardiac",
"lang": "EN"
},
{
"name": "心律失常",
"lang": "CN"
}
],
[
{
"name": "Atrial arrhythmia",
"lan... | [
"Small molecule drug"
] | Pending | 1,283,299,200,000 | [
[
{
"name": "Atrial Fibrillation",
"lang": "EN"
},
{
"name": "心房颤动",
"lang": "CN"
}
]
] | [
"European Union",
"Canada",
"Switzerland",
"Iceland",
"Liechtenstein",
"Norway",
"South Africa"
] |
[
{
"name": "索米妥昔单抗",
"lang": "CN"
},
{
"name": "Mirvetuximab soravtansine",
"lang": "EN"
}
] | [
{
"name": "Anti-FOLR1-monoclonal-antibody-maytansinoid-conjugate-IMGN-853",
"lang": "EN"
},
{
"name": "Mirvetuximab soravtansine (USAN/INN)",
"lang": "EN"
},
{
"name": "Mirvetuximab soravtansine-gynx",
"lang": "EN"
},
{
"name": "埃拉莫单抗",
"lang": "CN"
},
{
"name": "... | [
[
{
"name": "Folate receptor alpha",
"lang": "EN"
},
{
"name": "叶酸受体α",
"lang": "CN"
}
],
[
{
"name": "Tubulin",
"lang": "EN"
},
{
"name": "微管蛋白",
"lang": "CN"
}
]
] | [
[
{
"name": "Platinum-sensitive epithelial ovarian cancer",
"lang": "EN"
},
{
"name": "铂敏感性卵巢上皮癌",
"lang": "CN"
}
],
[
{
"name": "Fallopian Tube Carcinoma",
"lang": "EN"
},
{
"name": "输卵管癌",
"lang": "CN"
}
],
[
{
"name... | [
"Antibody drug conjugate (ADC)"
] | Phase 3 Clinical | 1,668,384,000,000 | [
[
{
"name": "Folate receptor-alpha positive, platinumresistant epithelial ovarian cancer",
"lang": "EN"
},
{
"name": "叶酸受体α 阳性铂类耐药的卵巢上皮癌",
"lang": "CN"
}
],
[
{
"name": "Folate receptor-alpha positive, platinumresistant fallopian tube cancer",
"lang": "EN"... | [
"United States",
"China",
"European Union",
"United Kingdom",
"Canada",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "达芦那韦",
"lang": "CN"
},
{
"name": "Darunavir",
"lang": "EN"
},
{
"name": "ダルナビル エタノール付加物",
"lang": "JP"
}
] | [
{
"name": "DRV",
"lang": "EN"
},
{
"name": "Darunavir Ethanolate",
"lang": "EN"
},
{
"name": "Darunavir ethanolate (JAN)",
"lang": "EN"
},
{
"name": "Virem",
"lang": "EN"
},
{
"name": "乙醇达芦那韦",
"lang": "CN"
},
{
"name": "地瑞那韦",
"lang": "CN"
}
] | [
[
{
"name": "Human immunodeficiency virus type 1 protease",
"lang": "EN"
},
{
"name": "人类免疫缺陷病毒1型蛋白酶",
"lang": "CN"
}
]
] | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
],
[
{
"name": "Acquired Immunodeficiency Syndrome",
"lang": "EN"
},
{
"name": "获得性免疫缺陷综合征",
"lang": "CN"
}
],
[
{
"name": "Hepatitis C",
... | [
"Small molecule drug"
] | Pending | 1,151,020,800,000 | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "辛酸拉尼米韦",
"lang": "CN"
},
{
"name": "Laninamivir Octanoate Hydrate",
"lang": "EN"
},
{
"name": "ラニナミビルオクタン酸エステル水和物",
"lang": "JP"
}
] | [
{
"name": "Inavir",
"lang": "EN"
},
{
"name": "LANI",
"lang": "EN"
},
{
"name": "Laninamivir",
"lang": "EN"
},
{
"name": "Laninamivir octanoate",
"lang": "EN"
},
{
"name": "Laninamivir octanoate hydrate (JAN)",
"lang": "EN"
},
{
"name": "イナビル",
"la... | [
[
{
"name": "Influenza A Neuraminidase",
"lang": "EN"
},
{
"name": "神经氨酸苷酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Influenza A virus infection",
"lang": "EN"
},
{
"name": "甲型流感病毒感染",
"lang": "CN"
}
],
[
{
"name": "Influenza B virus infection",
"lang": "EN"
},
{
"name": "乙型流感病毒感染",
"lang": "CN"
}
],
[
{
"name": "Asthma ... | [
"Small molecule drug"
] | Approved | 1,560,816,000,000 | [
[
{
"name": "Influenza A virus infection",
"lang": "EN"
},
{
"name": "甲型流感病毒感染",
"lang": "CN"
}
],
[
{
"name": "Influenza B virus infection",
"lang": "EN"
},
{
"name": "乙型流感病毒感染",
"lang": "CN"
}
]
] | [
"Japan"
] |
[
{
"name": "盐酸阿扑吗啡",
"lang": "CN"
},
{
"name": "Apomorphine Hydrochloride",
"lang": "EN"
},
{
"name": "アポモルヒネ塩酸塩水和物",
"lang": "JP"
}
] | [
{
"name": "Apomorphine Hydrochloride Hydrate",
"lang": "EN"
},
{
"name": "Apomorphine hydrochloride (USP)",
"lang": "EN"
},
{
"name": "Apomorphine hydrochloride hydrate (JAN)",
"lang": "EN"
},
{
"name": "Intranasal Apomorphine(Oncotelic)",
"lang": "EN"
},
{
"name"... | [
[
{
"name": "Dopamine receptors",
"lang": "EN"
},
{
"name": "多巴胺受体家族",
"lang": "CN"
}
]
] | [
[
{
"name": "Parkinson Disease",
"lang": "EN"
},
{
"name": "帕金森病",
"lang": "CN"
}
],
[
{
"name": "Erectile Dysfunction",
"lang": "EN"
},
{
"name": "勃起功能障碍",
"lang": "CN"
}
],
[
{
"name": "Female sexual dysfunction",
... | [
"Small molecule drug"
] | Preclinical | 991,008,000,000 | [
[
{
"name": "Erectile Dysfunction",
"lang": "EN"
},
{
"name": "勃起功能障碍",
"lang": "CN"
}
]
] | [
"United States",
"China",
"Japan",
"United Kingdom",
"Canada",
"Australia"
] |
[
{
"name": "马来酸氯苯那敏/氢溴酸东莨菪碱水合物/烟酰胺/盐酸吡哆醇",
"lang": "CN"
},
{
"name": "Chlorpheniramine Maleate/Scopolamine Hydrobromide Hydrate/Nicotinamide/Pyridoxine Hydrochloride",
"lang": "EN"
}
] | null | [
[
{
"name": "Histamine H1 receptor",
"lang": "EN"
},
{
"name": "组胺H1受体",
"lang": "CN"
}
],
[
{
"name": "Poly (ADP-Ribose) polymerase 1",
"lang": "EN"
},
{
"name": "聚腺苷二磷酸核糖聚合酶1",
"lang": "CN"
}
],
[
{
"name": "sphingom... | [
[
{
"name": "Motion Sickness",
"lang": "EN"
},
{
"name": "晕动病",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,762,473,600,000 | [
[
{
"name": "Motion Sickness",
"lang": "EN"
},
{
"name": "晕动病",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "罗替高汀",
"lang": "CN"
},
{
"name": "Rotigotine",
"lang": "EN"
},
{
"name": "ロチゴチン",
"lang": "JP"
}
] | [
{
"name": "(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol",
"lang": "EN"
},
{
"name": "N-0437 (undefined isomer)",
"lang": "EN"
},
{
"name": "Rotigotine (JAN/USAN/INN)",
"lang": "EN"
},
{
"name": "Rotigotine behenate",
"lang": "EN"
},
{
... | [
[
{
"name": "Dopamine D2 receptor",
"lang": "EN"
},
{
"name": "多巴胺D2受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Parkinson Disease",
"lang": "EN"
},
{
"name": "帕金森病",
"lang": "CN"
}
],
[
{
"name": "Restless Legs Syndrome",
"lang": "EN"
},
{
"name": "不宁腿综合征",
"lang": "CN"
}
],
[
{
"name": "Primary Parkinson's disease"... | [
"Small molecule drug"
] | Pending | 1,139,961,600,000 | [
[
{
"name": "Parkinson Disease",
"lang": "EN"
},
{
"name": "帕金森病",
"lang": "CN"
}
],
[
{
"name": "Restless Legs Syndrome",
"lang": "EN"
},
{
"name": "不宁腿综合征",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "氟[18]-PSMA-1007",
"lang": "CN"
},
{
"name": "18F-PSMA-1007",
"lang": "EN"
}
] | null | [
[
{
"name": "Prostate-specific membrane antigen",
"lang": "EN"
},
{
"name": "前列腺癌特异性膜抗原",
"lang": "CN"
}
]
] | [
[
{
"name": "Prostatic Cancer",
"lang": "EN"
},
{
"name": "前列腺癌",
"lang": "CN"
}
],
[
{
"name": "Recurrent Prostate Carcinoma",
"lang": "EN"
},
{
"name": "复发性前列腺癌",
"lang": "CN"
}
],
[
{
"name": "Adenocarcinoma of pros... | [
"Peptide Conjugate Radionuclide",
"Diagnostic radiopharmaceuticals"
] | NDA/BLA | 1,733,875,200,000 | [
[
{
"name": "Prostatic Cancer",
"lang": "EN"
},
{
"name": "前列腺癌",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "甲磺酸法舒地尔",
"lang": "CN"
},
{
"name": "Fasudil mesylate",
"lang": "EN"
}
] | [
{
"name": "Fasudil",
"lang": "EN"
}
] | [
[
{
"name": "Rho-associated protein kinase 1",
"lang": "EN"
},
{
"name": "Rho相关蛋白激酶-1",
"lang": "CN"
}
],
[
{
"name": "Voltage-gated calcium channel",
"lang": "EN"
},
{
"name": "电压门控性钙通道复合体",
"lang": "CN"
}
]
] | [
[
{
"name": "Brain Ischemia",
"lang": "EN"
},
{
"name": "脑缺血",
"lang": "CN"
}
],
[
{
"name": "Vasospasm, Intracranial",
"lang": "EN"
},
{
"name": "颅内血管痉挛",
"lang": "CN"
}
],
[
{
"name": "Corticobasal degeneration",
... | [
"Small molecule drug"
] | Phase 2 Clinical | 1,337,040,000,000 | [
[
{
"name": "Brain Ischemia",
"lang": "EN"
},
{
"name": "脑缺血",
"lang": "CN"
}
],
[
{
"name": "Vasospasm, Intracranial",
"lang": "EN"
},
{
"name": "颅内血管痉挛",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "依那西普生物类似药(鲁宾有限公司)",
"lang": "CN"
},
{
"name": "Etanercept biosimilar(Lupin Ltd)",
"lang": "EN"
},
{
"name": "エタネルセプト（遺伝子組換え)(日医工株式会社)",
"lang": "JP"
}
] | [
{
"name": "Etanercept Biosimilar (Lupin Ltd)",
"lang": "EN"
},
{
"name": "Nepexto",
"lang": "EN"
},
{
"name": "エタネルセプト（遺伝子組換え)(株式会社陽進堂)",
"lang": "JP"
},
{
"name": "依那西普生物类似药（Lupin Ltd）",
"lang": "CN"
}
] | [
[
{
"name": "Tumor necrosis factor α",
"lang": "EN"
},
{
"name": "肿瘤坏死因子α",
"lang": "CN"
}
],
[
{
"name": "Tumor necrosis factor β",
"lang": "EN"
},
{
"name": "肿瘤坏死因子β",
"lang": "CN"
}
]
] | [
[
{
"name": "Non-radiographic axial spondyloarthritis",
"lang": "EN"
},
{
"name": "非放射性轴性脊柱关节炎",
"lang": "CN"
}
],
[
{
"name": "Ankylosing Spondylitis",
"lang": "EN"
},
{
"name": "强直性脊柱炎",
"lang": "CN"
}
],
[
{
"name":... | [
"Fc fusion protein",
"Biosimilar"
] | Approved | 1,553,558,400,000 | [
[
{
"name": "Juvenile Idiopathic Arthritis",
"lang": "EN"
},
{
"name": "幼年特发性关节炎",
"lang": "CN"
}
],
[
{
"name": "Rheumatoid Arthritis",
"lang": "EN"
},
{
"name": "类风湿关节炎",
"lang": "CN"
}
]
] | [
"European Union",
"Japan",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "甲磺酸奥希替尼",
"lang": "CN"
},
{
"name": "Osimertinib mesylate",
"lang": "EN"
},
{
"name": "オシメルチニブメシル酸塩",
"lang": "JP"
}
] | [
{
"name": "ADAURA",
"lang": "EN"
},
{
"name": "Mereletinib",
"lang": "EN"
},
{
"name": "Osimertinib Mesilate",
"lang": "EN"
},
{
"name": "Osimertinib mesilate (JAN)",
"lang": "EN"
},
{
"name": "Osimertinib mesylate (USAN)",
"lang": "EN"
},
{
"name": "[... | [
[
{
"name": "EGFR exon 21 L858R mutation",
"lang": "EN"
},
{
"name": "EGFR21外显子L858R突变",
"lang": "CN"
}
],
[
{
"name": "Epidermal Growth Factor Receptor T790M",
"lang": "EN"
},
{
"name": "表皮生长因子受体T790M",
"lang": "CN"
}
],
[
... | [
[
{
"name": "Non-Small Cell Lung Cancer",
"lang": "EN"
},
{
"name": "非小细胞肺癌",
"lang": "CN"
}
],
[
{
"name": "EGFR positive non-small cell lung cancer",
"lang": "EN"
},
{
"name": "EGFR阳性非小细胞肺癌",
"lang": "CN"
}
],
[
{
"n... | [
"Small molecule drug"
] | Phase 2 Clinical | 1,447,372,800,000 | [
[
{
"name": "EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma",
"lang": "EN"
},
{
"name": "EGFR-T790M 突变非小细胞肺癌",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Australia",
"Switzerland",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "赛利司他",
"lang": "CN"
},
{
"name": "Cetilistat",
"lang": "EN"
},
{
"name": "セチリスタット",
"lang": "JP"
}
] | [
{
"name": "Cametor",
"lang": "EN"
},
{
"name": "Cetilistat (JAN/USAN/INN)",
"lang": "EN"
}
] | [
[
{
"name": "Gastric lipase",
"lang": "EN"
},
{
"name": "胃脂肪酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Obesity",
"lang": "EN"
},
{
"name": "肥胖",
"lang": "CN"
}
],
[
{
"name": "Diabetes Mellitus, Type 2",
"lang": "EN"
},
{
"name": "2型糖尿病",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Pending | 1,378,080,000,000 | [
[
{
"name": "Obesity",
"lang": "EN"
},
{
"name": "肥胖",
"lang": "CN"
}
]
] | [
"Japan"
] |
[
{
"name": "曲妥珠单抗生物类似药 (安徽安科)",
"lang": "CN"
},
{
"name": "Trastuzumab biosimilar (Anhui Anke)",
"lang": "EN"
}
] | [
{
"name": "Recombinant anti-HER2 antibody(Anhui Anke Biotech)",
"lang": "EN"
},
{
"name": "重组人HER2单抗 (安徽安科生物)",
"lang": "CN"
}
] | [
[
{
"name": "Receptor tyrosine-protein kinase erbB-2",
"lang": "EN"
},
{
"name": "受体蛋白酪氨酸激酶 erbB-2",
"lang": "CN"
}
]
] | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
],
[
{
"name": "HER2-positive gastric cancer",
"lang": "EN"
},
{
"name": "HER2阳性胃癌",
"lang": "CN"
}
],
[
{
"name": "Germl... | [
"Biosimilar",
"Monoclonal antibody"
] | Pending | 1,698,364,800,000 | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
],
[
{
"name": "HER2-positive gastric cancer",
"lang": "EN"
},
{
"name": "HER2阳性胃癌",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "多替拉韦钠/拉米夫定",
"lang": "CN"
},
{
"name": "Dolutegravir Sodium/Lamivudine",
"lang": "EN"
},
{
"name": "ドルテグラビルナトリウム・ラミブジン",
"lang": "JP"
}
] | [
{
"name": "Dolutegravir/Lamivudine",
"lang": "EN"
},
{
"name": "Lamivudine/dolutegravir",
"lang": "EN"
}
] | [
[
{
"name": "HIV integrase",
"lang": "EN"
},
{
"name": "HIV整合酶",
"lang": "CN"
}
],
[
{
"name": "Viral reverse transcriptase",
"lang": "EN"
},
{
"name": "逆转录酶",
"lang": "CN"
}
]
] | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
],
[
{
"name": "Pulmonary Tuberculosis",
"lang": "EN"
},
{
"name": "肺结核",
"lang": "CN"
}
],
[
{
"name": "Tuberculosis",
"lang": "EN"... | [
"Small molecule drug"
] | Phase 3 Clinical | 1,554,681,600,000 | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "非格司亭生物类似药(KASHIV BIOSCIENCES LLC)",
"lang": "CN"
},
{
"name": "Filgrastim biosimilar(KASHIV BIOSCIENCES LLC)",
"lang": "EN"
}
] | [
{
"name": "FILGRASTIM-AYOW",
"lang": "EN"
}
] | [
[
{
"name": "Colony stimulating factor 3 receptor",
"lang": "EN"
},
{
"name": "巨噬细胞集落刺激因子3受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Febrile Neutropenia",
"lang": "EN"
},
{
"name": "粒细胞减少性发热",
"lang": "CN"
}
],
[
{
"name": "Neutropenia",
"lang": "EN"
},
{
"name": "中性粒细胞减少",
"lang": "CN"
}
]
] | [
"Biosimilar",
"Colony-stimulating factors"
] | Approved | 1,645,747,200,000 | [
[
{
"name": "Febrile Neutropenia",
"lang": "EN"
},
{
"name": "粒细胞减少性发热",
"lang": "CN"
}
],
[
{
"name": "Neutropenia",
"lang": "EN"
},
{
"name": "中性粒细胞减少",
"lang": "CN"
}
]
] | [
"United States"
] |
[
{
"name": "玛贝兰妥单抗",
"lang": "CN"
},
{
"name": "Belantamab mafodotin",
"lang": "EN"
},
{
"name": "ベランタマブ マホドチン（遺伝子組換え）",
"lang": "JP"
}
] | [
{
"name": "Belamaf",
"lang": "EN"
},
{
"name": "Belantamab mafodotin (USAN)",
"lang": "EN"
},
{
"name": "Belantamab mafodotin (genetical recombination) (JAN)",
"lang": "EN"
},
{
"name": "anti-BCMA-ADC",
"lang": "EN"
},
{
"name": "belantamab mafodotin-blmf",
"l... | [
[
{
"name": "B-cell maturation protein",
"lang": "EN"
},
{
"name": "B细胞成熟蛋白",
"lang": "CN"
}
],
[
{
"name": "Tubulin",
"lang": "EN"
},
{
"name": "微管蛋白",
"lang": "CN"
}
]
] | [
[
{
"name": "Refractory Multiple Myeloma",
"lang": "EN"
},
{
"name": "难治性多发性骨髓瘤",
"lang": "CN"
}
],
[
{
"name": "Relapse multiple myeloma",
"lang": "EN"
},
{
"name": "复发性多发性骨髓瘤",
"lang": "CN"
}
],
[
{
"name": "Multiple... | [
"Antibody drug conjugate (ADC)"
] | Phase 3 Clinical | 1,596,585,600,000 | [
[
{
"name": "Multiple Myeloma",
"lang": "EN"
},
{
"name": "多发性骨髓瘤",
"lang": "CN"
}
],
[
{
"name": "Refractory Multiple Myeloma",
"lang": "EN"
},
{
"name": "难治性多发性骨髓瘤",
"lang": "CN"
}
],
[
{
"name": "Relapse multiple my... | [
"United States",
"China",
"European Union",
"Japan",
"United Kingdom",
"Canada",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "司美格鲁肽生物类似药（NATCO Pharma）",
"lang": "CN"
},
{
"name": "Semaglutide biosimilar (Natco Pharma)",
"lang": "EN"
}
] | [
{
"name": "Semaglutide Biosimilar (NATCO Pharma Ltd.)",
"lang": "EN"
}
] | [
[
{
"name": "Glucagon-like peptide 1 receptor",
"lang": "EN"
},
{
"name": "胰高血糖素样肽-1受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Diabetes Mellitus, Type 2",
"lang": "EN"
},
{
"name": "2型糖尿病",
"lang": "CN"
}
]
] | [
"Recombinant polypeptide",
"Biosimilar"
] | Approved | 1,773,964,800,000 | [
[
{
"name": "Diabetes Mellitus, Type 2",
"lang": "EN"
},
{
"name": "2型糖尿病",
"lang": "CN"
}
]
] | [
"India"
] |
[
{
"name": "Cepeginterferon alfa-2b",
"lang": "EN"
}
] | [
{
"name": "Algeron",
"lang": "EN"
},
{
"name": "Cepeginterferon Alfa 2 B",
"lang": "EN"
},
{
"name": "Cepeginterferon alfa 2b",
"lang": "EN"
},
{
"name": "Pegylated human interferon A-2B",
"lang": "EN"
}
] | [
[
{
"name": "Type I IFN Receptor",
"lang": "EN"
},
{
"name": "I型干扰素受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Hepatitis C",
"lang": "EN"
},
{
"name": "丙型肝炎",
"lang": "CN"
}
],
[
{
"name": "AIDS-Related Opportunistic Infections",
"lang": "EN"
},
{
"name": "艾滋病相关机会致病菌感染",
"lang": "CN"
}
],
[
{
"name": "Hepatitis C, ... | [
"Interferons"
] | Pending | 1,385,856,000,000 | [
[
{
"name": "Hepatitis C",
"lang": "EN"
},
{
"name": "丙型肝炎",
"lang": "CN"
}
]
] | [
"Russia"
] |
[
{
"name": "奥利万星磷酸盐",
"lang": "CN"
},
{
"name": "Oritavancin Diphosphate",
"lang": "EN"
}
] | [
{
"name": "Chlorobiphenyl-chloroeremomycin",
"lang": "EN"
},
{
"name": "Nuvocid",
"lang": "EN"
},
{
"name": "Oritavancin diphosphate (USAN)",
"lang": "EN"
},
{
"name": "Ramvocid",
"lang": "EN"
},
{
"name": "oritavancin",
"lang": "EN"
}
] | [
[
{
"name": "Peptidoglycan",
"lang": "EN"
},
{
"name": "肽聚糖",
"lang": "CN"
}
]
] | [
[
{
"name": "Skin and skin structure infections",
"lang": "EN"
},
{
"name": "皮肤和皮肤结构感染",
"lang": "CN"
}
],
[
{
"name": "Bacterial Infections",
"lang": "EN"
},
{
"name": "细菌感染",
"lang": "CN"
}
],
[
{
"name": "Cellulitis... | [
"Glycopeptide antibiotic",
"Cyclic Peptide"
] | NDA/BLA | 1,407,283,200,000 | [
[
{
"name": "Skin and skin structure infections",
"lang": "EN"
},
{
"name": "皮肤和皮肤结构感染",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"Canada",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "聚乙二醇洛塞那肽",
"lang": "CN"
},
{
"name": "PEG-Loxenatide",
"lang": "EN"
}
] | [
{
"name": "PEG loxenatide",
"lang": "EN"
},
{
"name": "Polyethylene Glycol Loxenatide",
"lang": "EN"
},
{
"name": "pegloxenatide",
"lang": "EN"
},
{
"name": "洛塞那肽",
"lang": "CN"
}
] | [
[
{
"name": "Glucagon-like peptide 1 receptor",
"lang": "EN"
},
{
"name": "胰高血糖素样肽-1受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Diabetes Mellitus, Type 2",
"lang": "EN"
},
{
"name": "2型糖尿病",
"lang": "CN"
}
]
] | [
"Synthetic peptide"
] | Approved | 1,557,014,400,000 | [
[
{
"name": "Diabetes Mellitus, Type 2",
"lang": "EN"
},
{
"name": "2型糖尿病",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "苹果酸奈诺沙星",
"lang": "CN"
},
{
"name": "Nemonoxacin Malate",
"lang": "EN"
}
] | [
{
"name": "Nemonoxacin",
"lang": "EN"
},
{
"name": "Taigexyn",
"lang": "EN"
}
] | [
[
{
"name": "Bacterial DNA gyrase",
"lang": "EN"
},
{
"name": "细菌DNA旋转酶",
"lang": "CN"
}
],
[
{
"name": "Bacterial topoisomerase IV",
"lang": "EN"
},
{
"name": "细菌拓扑异构酶IV",
"lang": "CN"
}
]
] | [
[
{
"name": "Community Acquired Pneumonia",
"lang": "EN"
},
{
"name": "社区获得性肺炎",
"lang": "CN"
}
],
[
{
"name": "Infectious Diseases",
"lang": "EN"
},
{
"name": "感染",
"lang": "CN"
}
],
[
{
"name": "Urinary Tract Infecti... | [
"Small molecule drug"
] | Pending | 1,464,307,200,000 | [
[
{
"name": "Community Acquired Pneumonia",
"lang": "EN"
},
{
"name": "社区获得性肺炎",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "托夫生",
"lang": "CN"
},
{
"name": "Tofersen",
"lang": "EN"
},
{
"name": "トフェルセン",
"lang": "JP"
}
] | [
{
"name": "ISIS-SOD1RX",
"lang": "EN"
},
{
"name": "Tofersen (JAN/USAN/INN)",
"lang": "EN"
},
{
"name": "Tofersen Sodium",
"lang": "EN"
}
] | [
[
{
"name": "Superoxide dismutase",
"lang": "EN"
},
{
"name": "超氧化物歧化酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Amyotrophic Lateral Sclerosis 1",
"lang": "EN"
},
{
"name": "1型肌萎缩侧索硬化",
"lang": "CN"
}
],
[
{
"name": "Amyotrophic Lateral Sclerosis",
"lang": "EN"
},
{
"name": "肌萎缩侧索硬化",
"lang": "CN"
}
]
] | [
"ASO"
] | Approved | 1,682,380,800,000 | [
[
{
"name": "Amyotrophic Lateral Sclerosis 1",
"lang": "EN"
},
{
"name": "1型肌萎缩侧索硬化",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"United Kingdom",
"Canada",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "噻康唑",
"lang": "CN"
},
{
"name": "Tioconazole",
"lang": "EN"
}
] | [
{
"name": "Tioconazole (JAN/USP/INN)",
"lang": "EN"
}
] | [
[
{
"name": "Fungal CYP51A1",
"lang": "EN"
},
{
"name": "真菌细胞色素P450家族成员51",
"lang": "CN"
}
]
] | [
[
{
"name": "Candidiasis, Vulvovaginal",
"lang": "EN"
},
{
"name": "外阴阴道念珠菌病",
"lang": "CN"
}
],
[
{
"name": "Tinea Versicolor",
"lang": "EN"
},
{
"name": "花斑癣",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Withdrawn | 414,374,400,000 | [
[
{
"name": "Tinea Versicolor",
"lang": "EN"
},
{
"name": "花斑癣",
"lang": "CN"
}
]
] | [
"United States"
] |
[
{
"name": "对乙酰氨基酚/愈创甘油醚/盐酸伪麻黄碱/盐酸甲基麻黄碱/氢溴酸右美沙芬/盐酸曲普利啶",
"lang": "CN"
},
{
"name": "Acetaminophen/Guaifenesin/Pseudoephedrine Hydrochloride/Methylephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/Triprolidine Hydrochloride",
"lang": "EN"
}
] | null | [
[
{
"name": "Histamine H1 receptor",
"lang": "EN"
},
{
"name": "组胺H1受体",
"lang": "CN"
}
],
[
{
"name": "Sigma opioid receptor",
"lang": "EN"
},
{
"name": "σ-阿片受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,724,284,800,000 | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "酒石酸泰瑞西利",
"lang": "CN"
},
{
"name": "Tibremciclib",
"lang": "EN"
}
] | [
{
"name": "泰瑞西利",
"lang": "CN"
},
{
"name": "酒石酸泰贝西利",
"lang": "CN"
}
] | [
[
{
"name": "Cyclin-dependent kinase 4",
"lang": "EN"
},
{
"name": "细胞周期蛋白依赖性激酶4",
"lang": "CN"
}
],
[
{
"name": "Cyclin-dependent kinase 6",
"lang": "EN"
},
{
"name": "细胞周期蛋白依赖性激酶6",
"lang": "CN"
}
]
] | [
[
{
"name": "Hormone receptor positive HER2 negative breast cancer",
"lang": "EN"
},
{
"name": "HR阳性/HER2阴性乳腺癌",
"lang": "CN"
}
],
[
{
"name": "Locally Advanced Malignant Solid Neoplasm",
"lang": "EN"
},
{
"name": "局部晚期恶性实体瘤",
"lang": "... | [
"Small molecule drug"
] | Phase 1 Clinical | 1,751,241,600,000 | [
[
{
"name": "Hormone receptor positive HER2 negative breast cancer",
"lang": "EN"
},
{
"name": "HR阳性/HER2阴性乳腺癌",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "维奈克拉",
"lang": "CN"
},
{
"name": "Venetoclax",
"lang": "EN"
},
{
"name": "ベネトクラクス",
"lang": "JP"
}
] | [
{
"name": "VENCLYXTO",
"lang": "EN"
},
{
"name": "Venetoclax (JAN/USAN/INN)",
"lang": "EN"
},
{
"name": "维奈妥拉",
"lang": "CN"
},
{
"name": "维奈托克",
"lang": "CN"
}
] | [
[
{
"name": "Apoptosis regulator Bcl-2",
"lang": "EN"
},
{
"name": "细胞凋亡调控因子Bcl-2",
"lang": "CN"
}
]
] | [
[
{
"name": "Mantle cell lymphoma recurrent",
"lang": "EN"
},
{
"name": "复发性套细胞淋巴瘤",
"lang": "CN"
}
],
[
{
"name": "Mantle cell lymphoma refractory",
"lang": "EN"
},
{
"name": "难治性套细胞淋巴瘤",
"lang": "CN"
}
],
[
{
"name":... | [
"Small molecule drug"
] | Discontinued | 1,460,332,800,000 | [
[
{
"name": "Chronic Lymphocytic Leukemia",
"lang": "EN"
},
{
"name": "慢性淋巴细胞白血病",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Australia",
"Switzerland",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "双嘧达莫",
"lang": "CN"
},
{
"name": "Dipyridamole",
"lang": "EN"
},
{
"name": "ジピリダモール",
"lang": "JP"
}
] | [
{
"name": "Dipyrdamole",
"lang": "EN"
},
{
"name": "Dipyriadamole",
"lang": "EN"
},
{
"name": "Dipyridamine",
"lang": "EN"
},
{
"name": "Dipyridamole (JP17/USP/INN)",
"lang": "EN"
},
{
"name": "Dipyridamote",
"lang": "EN"
},
{
"name": "Dipyudamine",
... | [
[
{
"name": "Phosphodiesterase 5A",
"lang": "EN"
},
{
"name": "磷酸二酯酶-5A",
"lang": "CN"
}
],
[
{
"name": "phosphodiesterase 4A",
"lang": "EN"
}
]
] | [
[
{
"name": "Angina Pectoris",
"lang": "EN"
},
{
"name": "心绞痛",
"lang": "CN"
}
],
[
{
"name": "Heart Failure",
"lang": "EN"
},
{
"name": "心脏衰竭",
"lang": "CN"
}
],
[
{
"name": "Myocardial Infarction",
"lang": "EN"... | [
"Small molecule drug"
] | Preclinical | -312,595,200,000 | [
[
{
"name": "Angina Pectoris",
"lang": "EN"
},
{
"name": "心绞痛",
"lang": "CN"
}
],
[
{
"name": "Heart Failure",
"lang": "EN"
},
{
"name": "心脏衰竭",
"lang": "CN"
}
],
[
{
"name": "Myocardial Infarction",
"lang": "EN"... | [
"China",
"Japan"
] |
[
{
"name": "地西他滨/西达尿苷",
"lang": "CN"
},
{
"name": "Decitabine/Cedazuridine",
"lang": "EN"
}
] | [
{
"name": "(4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine",
"lang": "EN"
},
{
"name": "Decitabine/E7727",
"lang": "EN"
},
{
"name": "Decitabine/cedazuridine",
"lang": "EN"
},
{
"name": "E-7727/decitabine",
"lang": "EN"
},
{
"name": "INQOVI",
"lang": "E... | [
[
{
"name": "Cytidine deaminase",
"lang": "EN"
},
{
"name": "胞嘧啶核苷脱氨酶",
"lang": "CN"
}
],
[
{
"name": "DNA (cytosine-5)-methyltransferase 1",
"lang": "EN"
},
{
"name": "DNA（胞嘧啶-5）-甲基转移酶-1",
"lang": "CN"
}
]
] | [
[
{
"name": "Acute Myeloid Leukemia",
"lang": "EN"
},
{
"name": "急性髓性白血病",
"lang": "CN"
}
],
[
{
"name": "Chronic Myelomonocytic Leukemia",
"lang": "EN"
},
{
"name": "慢性粒单核细胞白血病",
"lang": "CN"
}
],
[
{
"name": "Myelody... | [
"Small molecule drug"
] | Phase 2 Clinical | 1,594,080,000,000 | [
[
{
"name": "Myelodysplastic Syndromes",
"lang": "EN"
},
{
"name": "骨髓增生异常综合征",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"Canada",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "可伐利单抗",
"lang": "CN"
},
{
"name": "Crovalimab",
"lang": "EN"
},
{
"name": "クロバリマブ（遺伝子組換え）（JAN）",
"lang": "JP"
}
] | [
{
"name": "CROVALIMAB-AKKZ",
"lang": "EN"
},
{
"name": "Complement c5 inhibitory humanized recycling monoclonal antibody (rg-6107 )",
"lang": "EN"
},
{
"name": "Crovalimab (USAN/INN)",
"lang": "EN"
},
{
"name": "Crovalimab (genetical recombination) (JAN)",
"lang": "EN"
... | [
[
{
"name": "Complement C5",
"lang": "EN"
},
{
"name": "补体C5",
"lang": "CN"
}
]
] | [
[
{
"name": "Atypical Hemolytic Uremic Syndrome",
"lang": "EN"
},
{
"name": "非典型溶血性尿毒症综合征",
"lang": "CN"
}
],
[
{
"name": "Hemoglobinuria, Paroxysmal",
"lang": "EN"
},
{
"name": "阵发性睡眠性血红蛋白尿症",
"lang": "CN"
}
],
[
{
"n... | [
"Monoclonal antibody"
] | Approved | 1,707,177,600,000 | [
[
{
"name": "Hemoglobinuria, Paroxysmal",
"lang": "EN"
},
{
"name": "阵发性睡眠性血红蛋白尿症",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "Serelaxin",
"lang": "EN"
}
] | [
{
"name": "ConXn",
"lang": "EN"
},
{
"name": "Human relaxin 2 (relaxin h2)",
"lang": "EN"
},
{
"name": "Human relaxin recombinant",
"lang": "EN"
},
{
"name": "Reasanz",
"lang": "EN"
},
{
"name": "Recombinant human relaxin",
"lang": "EN"
},
{
"name": "R... | [
[
{
"name": "Relaxin receptor 1",
"lang": "EN"
},
{
"name": "松弛素受体-1",
"lang": "CN"
}
]
] | [
[
{
"name": "Heart Failure",
"lang": "EN"
},
{
"name": "心脏衰竭",
"lang": "CN"
}
],
[
{
"name": "Acute decompensated heart failure",
"lang": "EN"
},
{
"name": "急性失代偿性心力衰竭",
"lang": "CN"
}
],
[
{
"name": "Chronic heart fai... | [
"Peptide Hormone"
] | Pending | 1,420,070,400,000 | [
[
{
"name": "Heart Failure",
"lang": "EN"
},
{
"name": "心脏衰竭",
"lang": "CN"
}
]
] | [
"Russia"
] |
[
{
"name": "阿尼普酶",
"lang": "CN"
},
{
"name": "Anistreplase",
"lang": "EN"
}
] | [
{
"name": "APSAC",
"lang": "EN"
},
{
"name": "Anisoylated plasminogen streptokinase activator complex",
"lang": "EN"
},
{
"name": "Anistreplase (USAN/INN)",
"lang": "EN"
}
] | [
[
{
"name": "Plasminogen",
"lang": "EN"
},
{
"name": "纤溶酶原",
"lang": "CN"
}
]
] | [
[
{
"name": "Acute myocardial infarction",
"lang": "EN"
},
{
"name": "急性心肌梗塞",
"lang": "CN"
}
],
[
{
"name": "Thrombosis",
"lang": "EN"
},
{
"name": "血栓形成",
"lang": "CN"
}
]
] | [
"Enzyme"
] | Preclinical | 628,128,000,000 | [
[
{
"name": "Acute myocardial infarction",
"lang": "EN"
},
{
"name": "急性心肌梗塞",
"lang": "CN"
}
]
] | [
"United States"
] |
[
{
"name": "伐尼瑞韦",
"lang": "CN"
},
{
"name": "Vaniprevir",
"lang": "EN"
}
] | [
{
"name": "Vaniprevir (JAN/USAN/INN)",
"lang": "EN"
}
] | [
[
{
"name": "Hepatitis C virus serine protease, NS3/NS4A",
"lang": "EN"
},
{
"name": "丙型肝炎病毒NS3/NS4A丝氨酸蛋白酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Hepatitis C",
"lang": "EN"
},
{
"name": "丙型肝炎",
"lang": "CN"
}
],
[
{
"name": "Chronic hepatitis C genotype 1",
"lang": "EN"
},
{
"name": "慢性丙型肝炎基因型 1",
"lang": "CN"
}
],
[
{
"name": "Hepatitis C, Chronic"... | [
"Synthetic peptide",
"Cyclic Peptide"
] | Discontinued | 1,411,689,600,000 | [
[
{
"name": "Hepatitis C",
"lang": "EN"
},
{
"name": "丙型肝炎",
"lang": "CN"
}
]
] | [
"Japan"
] |
[
{
"name": "瑞拉利单抗",
"lang": "CN"
},
{
"name": "Relatlimab",
"lang": "EN"
}
] | [
{
"name": "Anti-LAG-3",
"lang": "EN"
},
{
"name": "Anti-LAG-3 monoclonal antibody (Bristol-Myers Squibb)",
"lang": "EN"
},
{
"name": "Anti-LAG-3(Bristol-Myers-Squibb)",
"lang": "EN"
},
{
"name": "Anti-lymphocyte activation gene 3 monoclonal antibody",
"lang": "EN"
},
... | [
[
{
"name": "Lymphocyte activation gene 3 protein",
"lang": "EN"
},
{
"name": "淋巴细胞活化基因3蛋白",
"lang": "CN"
}
]
] | [
[
{
"name": "Melanoma",
"lang": "EN"
},
{
"name": "黑色素瘤",
"lang": "CN"
}
],
[
{
"name": "Recurrent Lung Non-Squamous Non-Small Cell Carcinoma",
"lang": "EN"
},
{
"name": "复发性非鳞状非小细胞肺癌",
"lang": "CN"
}
],
[
{
"name": "U... | [
"Monoclonal antibody"
] | Discontinued | 1,748,563,200,000 | [
[
{
"name": "Melanoma",
"lang": "EN"
},
{
"name": "黑色素瘤",
"lang": "CN"
}
]
] | [
"United States"
] |
[
{
"name": "地舒单抗生物类似药(Amneal)",
"lang": "CN"
},
{
"name": "Denosumab biosimilar(Amneal)",
"lang": "EN"
}
] | [
{
"name": "Denosumab Biosimilar (Amneal Intermediate, Inc.)",
"lang": "EN"
},
{
"name": "地舒单抗生物类似药（Amneal Intermediate, Inc.）",
"lang": "CN"
}
] | [
[
{
"name": "Tumor necrosis factor ligand superfamily member 11",
"lang": "EN"
},
{
"name": "肿瘤坏死因子配体超家族成员11",
"lang": "CN"
}
]
] | [
[
{
"name": "Bone metastases",
"lang": "EN"
},
{
"name": "骨转移癌",
"lang": "CN"
}
],
[
{
"name": "Hypercalcemia",
"lang": "EN"
},
{
"name": "高钙血症",
"lang": "CN"
}
],
[
{
"name": "Multiple Myeloma",
"lang": "EN"
... | [
"Biosimilar",
"Monoclonal antibody"
] | Approved | 1,750,896,000,000 | [
[
{
"name": "Bone Cancer",
"lang": "EN"
},
{
"name": "骨癌",
"lang": "CN"
}
],
[
{
"name": "Giant Cell Tumor of Bone",
"lang": "EN"
},
{
"name": "骨巨细胞瘤",
"lang": "CN"
}
],
[
{
"name": "Glucocorticoid-induced osteoporosis... | [
"United States",
"European Union",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "咖啡因/茶苯海明/维生素B6",
"lang": "CN"
},
{
"name": "Caffeine/Dimenhydrinate/Pyridoxine Hydrochloride",
"lang": "EN"
}
] | null | [
[
{
"name": "Adenosine A2a receptor",
"lang": "EN"
},
{
"name": "腺苷A2a受体",
"lang": "CN"
}
],
[
{
"name": "Histamine H1 receptor",
"lang": "EN"
},
{
"name": "组胺H1受体",
"lang": "CN"
}
],
[
{
"name": "Adenosine A1 receptor... | [
[
{
"name": "Motion Sickness",
"lang": "EN"
},
{
"name": "晕动病",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,727,308,800,000 | [
[
{
"name": "Motion Sickness",
"lang": "EN"
},
{
"name": "晕动病",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "乌司奴单抗生物类似药（百奥泰）",
"lang": "CN"
},
{
"name": "Ustekinumab-hmny",
"lang": "EN"
}
] | [
{
"name": "Ustekinumab Biosimilar (Bio-Thera Solutions, Ltd.)",
"lang": "EN"
},
{
"name": "乌司奴单抗生物类似药（百奥泰生物制药股份有限公司）",
"lang": "CN"
},
{
"name": "重组人抗白介素12单克隆抗体(百奥泰生物)",
"lang": "CN"
}
] | [
[
{
"name": "Interleukin-12 subunit beta",
"lang": "EN"
},
{
"name": "白细胞介素-12β亚基",
"lang": "CN"
}
]
] | [
[
{
"name": "Crohn Disease",
"lang": "EN"
},
{
"name": "克罗恩病",
"lang": "CN"
}
],
[
{
"name": "Arthritis, Psoriatic",
"lang": "EN"
},
{
"name": "银屑病关节炎",
"lang": "CN"
}
],
[
{
"name": "Crohn's disease, active moderate",... | [
"Biosimilar",
"Monoclonal antibody"
] | Approved | 1,747,872,000,000 | [
[
{
"name": "Arthritis, Psoriatic",
"lang": "EN"
},
{
"name": "银屑病关节炎",
"lang": "CN"
}
],
[
{
"name": "Crohn's disease, active moderate",
"lang": "EN"
},
{
"name": "活动性中度克罗恩病",
"lang": "CN"
}
],
[
{
"name": "Crohn's di... | [
"United States",
"European Union",
"United Kingdom",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "Esuberaprost Sodium",
"lang": "EN"
},
{
"name": "エスベラプロストナトリウム",
"lang": "JP"
}
] | [
{
"name": "E-beraprost sodium",
"lang": "EN"
},
{
"name": "Esuberaprost",
"lang": "EN"
},
{
"name": "Esuberaprost potassium",
"lang": "EN"
},
{
"name": "Esuberaprost sodium (USAN)",
"lang": "EN"
}
] | [
[
{
"name": "Prostanoid IP receptor",
"lang": "EN"
},
{
"name": "前列腺素IP受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Occlusion of artery",
"lang": "EN"
},
{
"name": "动脉闭塞",
"lang": "CN"
}
],
[
{
"name": "Pulmonary Arterial Hypertension",
"lang": "EN"
},
{
"name": "肺动脉高压",
"lang": "CN"
}
],
[
{
"name": "Ulcer",
"lan... | [
"Small molecule drug"
] | Pending | 758,764,800,000 | [
[
{
"name": "Occlusion of artery",
"lang": "EN"
},
{
"name": "动脉闭塞",
"lang": "CN"
}
],
[
{
"name": "Pulmonary Arterial Hypertension",
"lang": "EN"
},
{
"name": "肺动脉高压",
"lang": "CN"
}
],
[
{
"name": "Ulcer",
"lan... | [
"South Korea"
] |
[
{
"name": "美法仑氟苯酰胺",
"lang": "CN"
},
{
"name": "Melphalan flufenamide hydrochloride",
"lang": "EN"
}
] | [
{
"name": "Mel-flufen",
"lang": "EN"
},
{
"name": "Melflufen",
"lang": "EN"
},
{
"name": "Melphalan-prodrug-Oncopeptides",
"lang": "EN"
},
{
"name": "美氟芬",
"lang": "CN"
}
] | [
[
{
"name": "DNA",
"lang": "EN"
},
{
"name": "DNA",
"lang": "CN"
}
]
] | [
[
{
"name": "Multiple Myeloma",
"lang": "EN"
},
{
"name": "多发性骨髓瘤",
"lang": "CN"
}
],
[
{
"name": "Refractory acute myeloid leukemia",
"lang": "EN"
},
{
"name": "难治性急性髓细胞白血病",
"lang": "CN"
}
],
[
{
"name": "Relapsing a... | [
"Peptide drug conjugates"
] | Preclinical | 1,614,297,600,000 | [
[
{
"name": "Multiple Myeloma",
"lang": "EN"
},
{
"name": "多发性骨髓瘤",
"lang": "CN"
}
]
] | [
"European Union",
"United Kingdom",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "利福霉素钠",
"lang": "CN"
},
{
"name": "Rifamycin Sodium",
"lang": "EN"
}
] | [
{
"name": "Relafalk",
"lang": "EN"
},
{
"name": "Rifamicine SV",
"lang": "EN"
},
{
"name": "Rifamycin",
"lang": "EN"
},
{
"name": "Rifamycin CR",
"lang": "EN"
},
{
"name": "Rifamycin SV",
"lang": "EN"
},
{
"name": "Rifamycin SV sodium salt",
"lang"... | [
[
{
"name": "DNA-directed RNA polymerase beta chain",
"lang": "EN"
},
{
"name": "DNA引导的RNA聚合酶β链",
"lang": "CN"
}
]
] | [
[
{
"name": "Dysentery",
"lang": "EN"
},
{
"name": "痢疾",
"lang": "CN"
}
],
[
{
"name": "Pulmonary Tuberculosis",
"lang": "EN"
},
{
"name": "肺结核",
"lang": "CN"
}
],
[
{
"name": "Gram-Positive Bacterial Infections",
... | [
"Small molecule drug"
] | Phase 2 Clinical | 949,363,200,000 | [
[
{
"name": "Pulmonary Tuberculosis",
"lang": "EN"
},
{
"name": "肺结核",
"lang": "CN"
}
]
] | [
"China",
"United Kingdom",
"Bulgaria",
"Germany",
"Denmark",
"Spain",
"Finland",
"Greece",
"Hungary",
"Italy",
"Poland",
"Portugal",
"Sweden"
] |
[
{
"name": "硫酸伪麻黄碱",
"lang": "CN"
},
{
"name": "Pseudoephedrine Sulfate",
"lang": "EN"
}
] | [
{
"name": "Pseudoephedrine sulfate (USP)",
"lang": "EN"
},
{
"name": "Pseudoephrine Sulfate",
"lang": "EN"
}
] | [
[
{
"name": "Adrenergic receptor alpha-1",
"lang": "EN"
},
{
"name": "肾上腺素能受体α-1家族",
"lang": "CN"
}
],
[
{
"name": "Adrenergic receptors alpha-2",
"lang": "EN"
},
{
"name": "肾上腺素能受体α-2家族",
"lang": "CN"
}
],
[
{
"name":... | [
[
{
"name": "Nasal Obstruction",
"lang": "EN"
},
{
"name": "鼻塞",
"lang": "CN"
}
],
[
{
"name": "Congestion of nasal mucosa",
"lang": "EN"
},
{
"name": "鼻粘膜充血",
"lang": "CN"
}
],
[
{
"name": "Rhinitis, Allergic",
... | [
"Small molecule drug"
] | Withdrawn | 341,712,000,000 | [
[
{
"name": "Congestion of nasal mucosa",
"lang": "EN"
},
{
"name": "鼻粘膜充血",
"lang": "CN"
}
],
[
{
"name": "Rhinitis, Allergic",
"lang": "EN"
},
{
"name": "过敏性鼻炎",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "伯舒替尼",
"lang": "CN"
},
{
"name": "Bosutinib Monohydrate",
"lang": "EN"
},
{
"name": "ボスチニブ水和物",
"lang": "JP"
}
] | [
{
"name": "BOSUTINIB",
"lang": "EN"
},
{
"name": "Bosutinib Hydrate",
"lang": "EN"
},
{
"name": "Bosutinib hydrate (JAN)",
"lang": "EN"
},
{
"name": "bosutinib (as monohydrate)",
"lang": "EN"
},
{
"name": "博苏替尼",
"lang": "CN"
}
] | [
[
{
"name": "Bcr-Abl tyrosine kinase",
"lang": "EN"
},
{
"name": "bcr-abl酪氨酸激酶",
"lang": "CN"
}
],
[
{
"name": "Tyrosine-protein kinase SRC",
"lang": "EN"
},
{
"name": "酪氨酸蛋白激酶SRC",
"lang": "CN"
}
]
] | [
[
{
"name": "Chronic Myelogenous Leukemia",
"lang": "EN"
},
{
"name": "慢性粒细胞性白血病",
"lang": "CN"
}
],
[
{
"name": "Ductus Arteriosus, Patent",
"lang": "EN"
},
{
"name": "动脉导管未闭",
"lang": "CN"
}
],
[
{
"name": "Accelerat... | [
"Small molecule drug"
] | Pending | 1,346,716,800,000 | [
[
{
"name": "Philadelphia chromosome positive chronic myelogenous leukemia",
"lang": "EN"
},
{
"name": "费城染色体阳性慢性粒细胞白血病",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"Japan",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "恩美曲妥珠单抗生物类似药(Zydus Cadila)",
"lang": "CN"
},
{
"name": "Trastuzumab emtansine biosimilar (Zydus Cadila)",
"lang": "EN"
}
] | [
{
"name": "ADO-Trastuzumab Emtansine Biosimilar (Zydus Cadila Healthcare Ltd.)",
"lang": "EN"
},
{
"name": "Trastuzumab emtansine (USAN/INN)",
"lang": "EN"
},
{
"name": "Trastuzumab emtansine (genetical recombination) (JAN)",
"lang": "EN"
},
{
"name": "Ujvira",
"lang": "E... | [
[
{
"name": "Receptor tyrosine-protein kinase erbB-2",
"lang": "EN"
},
{
"name": "受体蛋白酪氨酸激酶 erbB-2",
"lang": "CN"
}
],
[
{
"name": "Tubulin",
"lang": "EN"
},
{
"name": "微管蛋白",
"lang": "CN"
}
]
] | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
]
] | [
"Antibody drug conjugate (ADC)",
"Biosimilar"
] | Approved | 1,621,814,400,000 | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
]
] | [
"India"
] |
[
{
"name": "瑞玛奈珠单抗",
"lang": "CN"
},
{
"name": "Fremanezumab-VFRM",
"lang": "EN"
},
{
"name": "フレマネズマブ（遺伝子組換え）",
"lang": "JP"
}
] | [
{
"name": "Anti-CGRP monoclonal antibody",
"lang": "EN"
},
{
"name": "Anti-calcitonin gene-related peptide monoclonal antibody",
"lang": "EN"
},
{
"name": "Fremanezumab(Genetical Recombination)",
"lang": "EN"
},
{
"name": "fremanezumab",
"lang": "EN"
},
{
"name": ... | [
[
{
"name": "Calcitonin gene-related peptide",
"lang": "EN"
},
{
"name": "降钙素基因相关肽",
"lang": "CN"
}
]
] | [
[
{
"name": "Migraine Disorders",
"lang": "EN"
},
{
"name": "偏头痛",
"lang": "CN"
}
],
[
{
"name": "Bladder pain",
"lang": "EN"
},
{
"name": "膀胱痛",
"lang": "CN"
}
],
[
{
"name": "Cluster Headache",
"lang": "EN"
... | [
"Monoclonal antibody"
] | Discontinued | 1,536,883,200,000 | [
[
{
"name": "Migraine Disorders",
"lang": "EN"
},
{
"name": "偏头痛",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"Japan",
"United Kingdom",
"Canada",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "富马酸丙酚替诺福韦/恩曲他滨/比克替拉韦",
"lang": "CN"
},
{
"name": "Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate",
"lang": "EN"
},
{
"name": "ビクテグラビルナトリウム/エムトリシタビン/テノホビル アラフェナミドフマル酸塩",
"lang": "JP"
}
] | [
{
"name": "B/F/TAF",
"lang": "EN"
},
{
"name": "BIC/FTC/TAF",
"lang": "EN"
},
{
"name": "Bictegravir Sodium/Emtricitabine/Tenofovir Alafenamide Fumarate",
"lang": "EN"
},
{
"name": "Bictegravir/Emtricitabine/Tenofovir Alafenamide",
"lang": "EN"
},
{
"name": "Bicte... | [
[
{
"name": "HIV integrase",
"lang": "EN"
},
{
"name": "HIV整合酶",
"lang": "CN"
}
],
[
{
"name": "Viral reverse transcriptase",
"lang": "EN"
},
{
"name": "逆转录酶",
"lang": "CN"
}
]
] | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
],
[
{
"name": "Fasting",
"lang": "EN"
},
{
"name": "禁食",
"lang": "CN"
}
],
[
{
"name": "Hepatitis B",
"lang": "EN"
},
{
... | [
"Small molecule drug"
] | Discontinued | 1,517,961,600,000 | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "重组人干扰素α-2b(Merck Sharp & Dohme )",
"lang": "CN"
},
{
"name": "INTERFERON ALFA-2B(Merck Sharp & Dohme )",
"lang": "EN"
}
] | [
{
"name": "Interferon alfa-2b (Merck Sharp & Dohme)",
"lang": "EN"
},
{
"name": "interferon alfa-2b",
"lang": "EN"
},
{
"name": "干扰素α-2b（默沙东）",
"lang": "CN"
}
] | [
[
{
"name": "Type I IFN Receptor",
"lang": "EN"
},
{
"name": "I型干扰素受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Hepatitis C",
"lang": "EN"
},
{
"name": "丙型肝炎",
"lang": "CN"
}
],
[
{
"name": "Kaposi Sarcoma",
"lang": "EN"
},
{
"name": "卡波西肉瘤",
"lang": "CN"
}
],
[
{
"name": "AIDS-related Kaposi Sarcoma",
"lang":... | [
"Interferons"
] | Withdrawn | 518,227,200,000 | [
[
{
"name": "AIDS-related Kaposi Sarcoma",
"lang": "EN"
},
{
"name": "艾滋病相关性卡波西肉瘤",
"lang": "CN"
}
],
[
{
"name": "Condylomata Acuminata",
"lang": "EN"
},
{
"name": "尖锐湿疣",
"lang": "CN"
}
],
[
{
"name": "Follicular Lym... | [
"United States",
"China"
] |
[
{
"name": "Upacicalcet Sodium Hydrate",
"lang": "EN"
},
{
"name": "ウパシカルセトナトリウム水和物",
"lang": "JP"
}
] | [
{
"name": "Upacicalcet",
"lang": "EN"
}
] | [
[
{
"name": "Calcium sensing receptor",
"lang": "EN"
},
{
"name": "钙敏感受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Hyperparathyroidism, Secondary",
"lang": "EN"
},
{
"name": "继发性甲状旁腺功能亢进症",
"lang": "CN"
}
],
[
{
"name": "Kidney Failure, Chronic",
"lang": "EN"
},
{
"name": "终末期肾脏病",
"lang": "CN"
}
],
[
{
"name": "Hyperp... | [
"Small molecule drug"
] | Phase 3 Clinical | 1,624,406,400,000 | [
[
{
"name": "Hyperparathyroidism, Secondary",
"lang": "EN"
},
{
"name": "继发性甲状旁腺功能亢进症",
"lang": "CN"
}
]
] | [
"Japan"
] |
[
{
"name": "罗特西普",
"lang": "CN"
},
{
"name": "Luspatercept-AAMT",
"lang": "EN"
},
{
"name": "ルスパテルセプト",
"lang": "JP"
}
] | [
{
"name": "Luspatercept",
"lang": "EN"
}
] | [
[
{
"name": "Activin receptor type-2B",
"lang": "EN"
},
{
"name": "激活素受体-2B",
"lang": "CN"
}
],
[
{
"name": "growth differentiation factor 11",
"lang": "EN"
}
]
] | [
[
{
"name": "Non-transfusion dependent thalassaemia",
"lang": "EN"
},
{
"name": "非输血依赖性地中海贫血",
"lang": "CN"
}
],
[
{
"name": "Anemia",
"lang": "EN"
},
{
"name": "贫血",
"lang": "CN"
}
],
[
{
"name": "Anemia, Sideroblasti... | [
"Fc fusion protein"
] | Phase 3 Clinical | 1,573,171,200,000 | [
[
{
"name": "Beta-Thalassemia",
"lang": "EN"
},
{
"name": "β地中海贫血",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "人纤维蛋白原(成都蓉生药业)",
"lang": "CN"
},
{
"name": "Human Fibrinogen(Chengdu Rongsheng Pharmaceutical)",
"lang": "EN"
}
] | null | [
[
{
"name": "Fibrinogen",
"lang": "EN"
},
{
"name": "纤维蛋白原",
"lang": "CN"
}
]
] | [
[
{
"name": "Afibrinogenemia",
"lang": "EN"
},
{
"name": "纤维蛋白原缺乏血症",
"lang": "CN"
}
],
[
{
"name": "Acquired fibrinogen deficiency",
"lang": "EN"
},
{
"name": "获得性纤维蛋白原缺乏",
"lang": "CN"
}
]
] | [
"Non-recombinant coagulation factor"
] | Phase 3 Clinical | 915,148,800,000 | [
[
{
"name": "Afibrinogenemia",
"lang": "EN"
},
{
"name": "纤维蛋白原缺乏血症",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "重组人凝血酶 (CHO细胞) (泽璟生物)",
"lang": "CN"
},
{
"name": "Recombinant human thrombin (Zelgen Biopharma)",
"lang": "EN"
}
] | [
{
"name": "Recombinant thrombin",
"lang": "EN"
},
{
"name": "Zepning",
"lang": "EN"
},
{
"name": "rThrombin",
"lang": "EN"
},
{
"name": "recombinant human thrombin",
"lang": "EN"
},
{
"name": "rhThrombin",
"lang": "EN"
}
] | [
[
{
"name": "Prothrombin",
"lang": "EN"
},
{
"name": "凝血酶原",
"lang": "CN"
}
]
] | [
[
{
"name": "Hemorrhage",
"lang": "EN"
},
{
"name": "出血",
"lang": "CN"
}
]
] | [
"Recombinant coagulation factor"
] | Approved | 1,703,548,800,000 | [
[
{
"name": "Hemorrhage",
"lang": "EN"
},
{
"name": "出血",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "糠酸氟替卡松/乌美溴铵/三苯乙酸维兰特罗",
"lang": "CN"
},
{
"name": "Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate",
"lang": "EN"
},
{
"name": "フルチカゾンフランカルボン酸エステル/ウメクリジニウム臭化物/ビランテロールトリフェニル酢酸塩",
"lang": "JP"
}
] | [
{
"name": "Closed Triple",
"lang": "EN"
},
{
"name": "Elebrato Ellipta",
"lang": "EN"
},
{
"name": "FF/UMEC/VI",
"lang": "EN"
},
{
"name": "Fluticasone Furoate/Umeclidinium/Vilanterol",
"lang": "EN"
},
{
"name": "Fluticasone Furoate/Umeclidinium/Vilanterol Trifena... | [
[
{
"name": "Glucocorticoid receptor",
"lang": "EN"
},
{
"name": "糖皮质激素受体",
"lang": "CN"
}
],
[
{
"name": "Muscarinic acetylcholine receptor M1",
"lang": "EN"
},
{
"name": "毒蕈碱型乙酰胆碱受体M1",
"lang": "CN"
}
],
[
{
"name": ... | [
[
{
"name": "Asthma",
"lang": "EN"
},
{
"name": "哮喘",
"lang": "CN"
}
],
[
{
"name": "Bronchitis, Chronic",
"lang": "EN"
},
{
"name": "慢性支气管炎",
"lang": "CN"
}
],
[
{
"name": "Pulmonary Disease, Chronic Obstructive",
... | [
"Small molecule drug"
] | Pending | 1,505,692,800,000 | [
[
{
"name": "Pulmonary Disease, Chronic Obstructive",
"lang": "EN"
},
{
"name": "慢性阻塞性肺疾病",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Iceland",
"Liechtenstein",
"Norway",
"Singapore"
] |
[
{
"name": "血管紧张素II",
"lang": "CN"
},
{
"name": "Angiotensin II Acetate",
"lang": "EN"
},
{
"name": "アンギオテンシンⅡ（ヒト型）",
"lang": "JP"
}
] | [
{
"name": "5-L-isoleucineangiotensin II",
"lang": "EN"
},
{
"name": "5-isoleucine-angiotensin II",
"lang": "EN"
},
{
"name": "ANGII",
"lang": "EN"
},
{
"name": "Angiotensin",
"lang": "EN"
},
{
"name": "Angiotensin II (human)",
"lang": "EN"
},
{
"name":... | [
[
{
"name": "Angiotensin II Receptor Type 1",
"lang": "EN"
},
{
"name": "血管紧张素II-1型受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Distributive shock",
"lang": "EN"
},
{
"name": "分布性休克",
"lang": "CN"
}
],
[
{
"name": "Hypotension",
"lang": "EN"
},
{
"name": "低血压",
"lang": "CN"
}
],
[
{
"name": "Shock, Septic",
"lang": "EN"
}... | [
"Synthetic peptide"
] | Pending | 1,513,814,400,000 | [
[
{
"name": "Shock",
"lang": "EN"
},
{
"name": "休克",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "地西他滨",
"lang": "CN"
},
{
"name": "Decitabine",
"lang": "EN"
}
] | [
{
"name": "2'-deoxy-5-azacytidine",
"lang": "EN"
},
{
"name": "4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one",
"lang": "EN"
},
{
"name": "4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one",
"lang": "EN"
},
{
"name": "5-aza-2'-deoxy... | [
[
{
"name": "DNA (cytosine-5)-methyltransferase 1",
"lang": "EN"
},
{
"name": "DNA（胞嘧啶-5）-甲基转移酶-1",
"lang": "CN"
}
]
] | [
[
{
"name": "Acute Myeloid Leukemia",
"lang": "EN"
},
{
"name": "急性髓性白血病",
"lang": "CN"
}
],
[
{
"name": "Myelodysplastic Syndromes",
"lang": "EN"
},
{
"name": "骨髓增生异常综合征",
"lang": "CN"
}
],
[
{
"name": "Advanced Tripl... | [
"Small molecule drug"
] | Discontinued | 1,146,528,000,000 | [
[
{
"name": "Anemia, Refractory, With Excess of Blasts",
"lang": "EN"
},
{
"name": "难治性贫血伴原始细胞过多",
"lang": "CN"
}
],
[
{
"name": "Anemia, Refractory",
"lang": "EN"
},
{
"name": "难治性贫血",
"lang": "CN"
}
],
[
{
"name": "C... | [
"China",
"European Union",
"Canada",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "苯磺酸氨氯地平/缬沙坦/氯噻酮",
"lang": "CN"
},
{
"name": "Amlodipine Besylate/Valsartan/Chlorthalidone",
"lang": "EN"
}
] | null | [
[
{
"name": "Angiotensin II Receptor Type 1",
"lang": "EN"
},
{
"name": "血管紧张素II-1型受体",
"lang": "CN"
}
],
[
{
"name": "Thiazide-sensitive sodium-chloride cotransporter",
"lang": "EN"
},
{
"name": "噻嗪类敏感氯化钠协同转运蛋白",
"lang": "CN"
}
]... | [
[
{
"name": "Essential Hypertension",
"lang": "EN"
},
{
"name": "原发性高血压",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,762,473,600,000 | [
[
{
"name": "Essential Hypertension",
"lang": "EN"
},
{
"name": "原发性高血压",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "Acetaminophen/Anhydrous Caffeine/Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/DL-Methylephedrine Hydrochloride/Thiamine Nitrate/Ascorbic Acid",
"lang": "EN"
}
] | [
{
"name": "对乙酰氨基酚/咖啡因/马来酸氯苯那敏/盐酸伪麻黄碱/盐酸甲基麻黄碱/硝酸硫胺/维生素C",
"lang": "EN"
}
] | [
[
{
"name": "Adenosine A2a receptor",
"lang": "EN"
},
{
"name": "腺苷A2a受体",
"lang": "CN"
}
],
[
{
"name": "Histamine H1 receptor",
"lang": "EN"
},
{
"name": "组胺H1受体",
"lang": "CN"
}
],
[
{
"name": "Adenosine A1 receptor... | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,735,862,400,000 | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "奥马珠单抗生物类似药 (Celltrion)",
"lang": "CN"
},
{
"name": "Omalizumab-igec",
"lang": "EN"
}
] | [
{
"name": "Omalizumab Biosimilar (Celltrion, Inc.)",
"lang": "EN"
},
{
"name": "Xolair biosimilar",
"lang": "EN"
},
{
"name": "Xolair biosimilar-Celltrion",
"lang": "EN"
},
{
"name": "奥马珠单抗生物类似药（Celltrion, Inc.）",
"lang": "CN"
}
] | [
[
{
"name": "Immunoglobulin E",
"lang": "EN"
},
{
"name": "免疫球蛋白E",
"lang": "CN"
}
]
] | [
[
{
"name": "Food Hypersensitivity",
"lang": "EN"
},
{
"name": "食物过敏",
"lang": "CN"
}
],
[
{
"name": "Moderate persistent asthma",
"lang": "EN"
},
{
"name": "中度持续性哮喘",
"lang": "CN"
}
],
[
{
"name": "Severe persistent a... | [
"Biosimilar",
"Monoclonal antibody"
] | Approved | 1,715,817,600,000 | [
[
{
"name": "Allergic asthma",
"lang": "EN"
},
{
"name": "过敏性哮喘",
"lang": "CN"
}
],
[
{
"name": "Chronic rhinosinusitis with nasal polyps",
"lang": "EN"
},
{
"name": "慢性鼻窦炎伴鼻息肉",
"lang": "CN"
}
],
[
{
"name": "Chronic ... | [
"United States",
"European Union",
"Canada",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "甲苯磺酸索拉非尼",
"lang": "CN"
},
{
"name": "Sorafenib Tosylate",
"lang": "EN"
},
{
"name": "ソラフェニブトシル酸塩",
"lang": "JP"
}
] | [
{
"name": "N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea",
"lang": "EN"
},
{
"name": "SORAFENIB",
"lang": "EN"
},
{
"name": "Sorafenib tosilate",
"lang": "EN"
},
{
"name": "Sorafenib tosilate (JAN)",
"lang": "EN"
},
{
... | [
[
{
"name": "Serine/threonine-protein kinase B-raf",
"lang": "EN"
},
{
"name": "丝氨酸/苏氨酸蛋白激酶B-raf",
"lang": "CN"
}
],
[
{
"name": "C-Raf kinase",
"lang": "EN"
},
{
"name": "C-Raf激酶",
"lang": "CN"
}
],
[
{
"name": "Tyros... | [
[
{
"name": "Thyroid Cancer",
"lang": "EN"
},
{
"name": "甲状腺癌",
"lang": "CN"
}
],
[
{
"name": "Unresectable Hepatocellular Carcinoma",
"lang": "EN"
},
{
"name": "不可切除的肝细胞癌",
"lang": "CN"
}
],
[
{
"name": "Advanced Hepa... | [
"Small molecule drug"
] | Pending | 1,133,395,200,000 | [
[
{
"name": "Advanced Renal Cell Carcinoma",
"lang": "EN"
},
{
"name": "晚期肾细胞癌",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "Alpha-1-Proteinase Inhibitor (Human)(Takeda)",
"lang": "EN"
}
] | null | [
[
{
"name": "Leukocyte elastase",
"lang": "EN"
},
{
"name": "白细胞弹性蛋白酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Pulmonary Emphysema",
"lang": "EN"
},
{
"name": "肺气肿",
"lang": "CN"
}
],
[
{
"name": "Alpha 1-Antitrypsin Deficiency",
"lang": "EN"
},
{
"name": "α1-抗胰蛋白酶缺乏症",
"lang": "CN"
}
]
] | [
"Blood components",
"Enzyme"
] | Discontinued | 1,040,601,600,000 | [
[
{
"name": "Alpha 1-Antitrypsin Deficiency",
"lang": "EN"
},
{
"name": "α1-抗胰蛋白酶缺乏症",
"lang": "CN"
}
]
] | [
"United States"
] |
[
{
"name": "帕妥珠单抗生物类似药 (正大天晴)",
"lang": "CN"
},
{
"name": "Pertuzumab biosimilar (Chia-tai Tianqing)",
"lang": "EN"
}
] | [
{
"name": "Pertuzumab Biosimilar (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.)",
"lang": "EN"
},
{
"name": "帕妥珠单抗生物类似药（正大天晴药业集团股份有限公司）",
"lang": "CN"
}
] | [
[
{
"name": "Receptor tyrosine-protein kinase erbB-2",
"lang": "EN"
},
{
"name": "受体蛋白酪氨酸激酶 erbB-2",
"lang": "CN"
}
]
] | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
],
[
{
"name": "Locally advanced breast cancer",
"lang": "EN"
},
{
"name": "局部晚期乳腺癌",
"lang": "CN"
}
],
[
{
"name": "Meta... | [
"Biosimilar",
"Monoclonal antibody"
] | Phase 3 Clinical | 1,734,393,600,000 | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "盐酸甲哌卡因",
"lang": "CN"
},
{
"name": "Mepivacaine Hydrochloride",
"lang": "EN"
},
{
"name": "メピバカイン塩酸塩",
"lang": "JP"
}
] | [
{
"name": "(+-)-1-Methyl-2',6'-pipecoloxylidide",
"lang": "EN"
},
{
"name": "1-methyl-2',6'-pipecoloxylidide",
"lang": "EN"
},
{
"name": "DL-Mepivacaine",
"lang": "EN"
},
{
"name": "MepiGel",
"lang": "EN"
},
{
"name": "Mepivacaine",
"lang": "EN"
},
{
"... | [
[
{
"name": "Voltage-gated sodium channels",
"lang": "EN"
},
{
"name": "电压门控钠离子通道",
"lang": "CN"
}
]
] | [
[
{
"name": "Anesthesia",
"lang": "EN"
},
{
"name": "麻醉",
"lang": "CN"
}
],
[
{
"name": "Brachial Plexus Neuropathies",
"lang": "EN"
},
{
"name": "臂丛神经病",
"lang": "CN"
}
],
[
{
"name": "Diabetic Neuropathies",
"l... | [
"Small molecule drug"
] | Pending | -441,849,600,000 | [
[
{
"name": "Anesthesia",
"lang": "EN"
},
{
"name": "麻醉",
"lang": "CN"
}
]
] | [
"China",
"Japan"
] |
[
{
"name": "硫酸氢氯吡格雷",
"lang": "CN"
},
{
"name": "Clopidogrel Bisulfate",
"lang": "EN"
},
{
"name": "クロピドグレル硫酸塩",
"lang": "JP"
}
] | [
{
"name": "Clopidogrel Bisufate",
"lang": "EN"
},
{
"name": "Clopidogrel Hydrogen Bisulfate",
"lang": "EN"
},
{
"name": "Clopidogrel Hydrogen sulphate Granules",
"lang": "EN"
},
{
"name": "Clopidogrel Sulfate",
"lang": "EN"
},
{
"name": "Clopidogrel bisulfate (USP... | [
[
{
"name": "Purinergic receptor P2Y12",
"lang": "EN"
},
{
"name": "嘌呤P2Y12受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Atherosclerosis",
"lang": "EN"
},
{
"name": "动脉粥样硬化",
"lang": "CN"
}
],
[
{
"name": "Ischemia",
"lang": "EN"
},
{
"name": "缺血",
"lang": "CN"
}
],
[
{
"name": "Angina, Stable",
"lang": "EN"
},
... | [
"Small molecule drug"
] | Pending | 879,724,800,000 | [
[
{
"name": "Myocardial Infarction",
"lang": "EN"
},
{
"name": "心肌梗塞",
"lang": "CN"
}
],
[
{
"name": "Stroke",
"lang": "EN"
},
{
"name": "脑卒中",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "多利培南",
"lang": "CN"
},
{
"name": "Doripenem",
"lang": "EN"
},
{
"name": "ドリペネム水和物",
"lang": "JP"
}
] | [
{
"name": "DRPM",
"lang": "EN"
},
{
"name": "Doripenem Hydrate",
"lang": "EN"
},
{
"name": "Doripenem hydrate (JP17)",
"lang": "EN"
},
{
"name": "Finibax IV",
"lang": "EN"
},
{
"name": "Finibax Kit",
"lang": "EN"
},
{
"name": "doripenem monohydrate",
... | [
[
{
"name": "Bacterial penicillin-binding protein",
"lang": "EN"
},
{
"name": "细菌青霉素结合蛋白家族",
"lang": "CN"
}
]
] | [
[
{
"name": "Meningococcal Infections",
"lang": "EN"
},
{
"name": "脑膜炎球菌感染",
"lang": "CN"
}
],
[
{
"name": "Paediatric infections",
"lang": "EN"
},
{
"name": "小儿感染",
"lang": "CN"
}
],
[
{
"name": "Gram-Negative Bacteri... | [
"Small molecule drug"
] | Discontinued | 1,122,249,600,000 | [
[
{
"name": "Bacterial Infections",
"lang": "EN"
},
{
"name": "细菌感染",
"lang": "CN"
}
],
[
{
"name": "Respiratory Tract Infections",
"lang": "EN"
},
{
"name": "呼吸道感染",
"lang": "CN"
}
]
] | [
"Japan"
] |
[
{
"name": "伏立诺他",
"lang": "CN"
},
{
"name": "Vorinostat",
"lang": "EN"
},
{
"name": "ボリノスタット",
"lang": "JP"
}
] | [
{
"name": "Octanedioic acid hydroxyamide phenylamide",
"lang": "EN"
},
{
"name": "SAHA",
"lang": "EN"
},
{
"name": "SHH",
"lang": "EN"
},
{
"name": "Suberanilohydroxamic acid",
"lang": "EN"
},
{
"name": "Suberoylanilide hydroxamic acid",
"lang": "EN"
},
{
... | [
[
{
"name": "Histone deacetylase",
"lang": "EN"
},
{
"name": "组蛋白去乙酰化酶家族",
"lang": "CN"
}
]
] | [
[
{
"name": "Cutaneous T-Cell Lymphoma",
"lang": "EN"
},
{
"name": "皮肤T细胞淋巴瘤",
"lang": "CN"
}
],
[
{
"name": "Anus Neoplasms",
"lang": "EN"
},
{
"name": "肛门肿瘤",
"lang": "CN"
}
],
[
{
"name": "Penile Neoplasms",
"... | [
"Small molecule drug"
] | Pending | 1,160,092,800,000 | [
[
{
"name": "Cutaneous T-Cell Lymphoma",
"lang": "EN"
},
{
"name": "皮肤T细胞淋巴瘤",
"lang": "CN"
}
]
] | [
"United States",
"Japan",
"Australia"
] |
[
{
"name": "依林扎奈坦",
"lang": "CN"
},
{
"name": "Elinzanetant",
"lang": "EN"
}
] | null | [
[
{
"name": "Neurokinin 1 receptor",
"lang": "EN"
},
{
"name": "神经激肽-1-受体",
"lang": "CN"
}
],
[
{
"name": "Neurokinin 3 receptor",
"lang": "EN"
},
{
"name": "神经激肽-3-受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Vasomotor symptom",
"lang": "EN"
},
{
"name": "血管舒缩症",
"lang": "CN"
}
],
[
{
"name": "Hot Flashes",
"lang": "EN"
},
{
"name": "潮热",
"lang": "CN"
}
],
[
{
"name": "Sleep Initiation and Maintenance Disorders... | [
"Small molecule drug"
] | Phase 2 Clinical | 1,751,328,000,000 | [
[
{
"name": "Hot Flashes",
"lang": "EN"
},
{
"name": "潮热",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"United Kingdom",
"Canada",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "特立帕肽生物类似药 (Teva Pharmaceuticals)",
"lang": "CN"
},
{
"name": "Teriparatide Biosimilar (Teva Pharmaceuticals)",
"lang": "EN"
}
] | null | [
[
{
"name": "Parathyroid hormone receptor",
"lang": "EN"
},
{
"name": "甲状旁腺激素受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Osteoporosis",
"lang": "EN"
},
{
"name": "骨质疏松症",
"lang": "CN"
}
]
] | [
"Recombinant polypeptide",
"Biosimilar",
"Peptide Hormone"
] | Approved | 1,700,092,800,000 | [
[
{
"name": "Osteoporosis",
"lang": "EN"
},
{
"name": "骨质疏松症",
"lang": "CN"
}
]
] | [
"United States"
] |
[
{
"name": "盐酸曲美苄胺",
"lang": "CN"
},
{
"name": "Trimethobenzamide Hydrochloride",
"lang": "EN"
}
] | [
{
"name": "N-[[4-(2-dimethylaminoethoxy)phenyl]methyl]-3,4,5-trimethoxybenzamide",
"lang": "EN"
},
{
"name": "Trimethobenzamide",
"lang": "EN"
},
{
"name": "Trimethobenzamide hydrochloride (USP)",
"lang": "EN"
}
] | [
[
{
"name": "Histamine receptor",
"lang": "EN"
},
{
"name": "组胺受体家族",
"lang": "CN"
}
]
] | [
[
{
"name": "Gastroenteritis",
"lang": "EN"
},
{
"name": "胃肠炎",
"lang": "CN"
}
],
[
{
"name": "Postoperative Nausea and Vomiting",
"lang": "EN"
},
{
"name": "术后恶心呕吐",
"lang": "CN"
}
],
[
{
"name": "Nausea",
"lang... | [
"Small molecule drug"
] | Pending | 142,819,200,000 | [
[
{
"name": "Gastroenteritis",
"lang": "EN"
},
{
"name": "胃肠炎",
"lang": "CN"
}
],
[
{
"name": "Postoperative Nausea and Vomiting",
"lang": "EN"
},
{
"name": "术后恶心呕吐",
"lang": "CN"
}
]
] | [
"United States"
] |
[
{
"name": "盐酸阿思尼布",
"lang": "CN"
},
{
"name": "Asciminib Hydrochloride",
"lang": "EN"
},
{
"name": "アシミニブ塩酸塩",
"lang": "JP"
}
] | [
{
"name": "Asciminib",
"lang": "EN"
},
{
"name": "阿思尼布",
"lang": "CN"
},
{
"name": "阿西米尼",
"lang": "CN"
}
] | [
[
{
"name": "Bcr-Abl tyrosine kinase",
"lang": "EN"
},
{
"name": "bcr-abl酪氨酸激酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase with the T315I mutation",
"lang": "EN"
},
{
"name": "T315I 突变的慢性期费城染色体阳性慢性粒细胞白血病",
"lang": "CN"
}
],
[
{
"name": "Philadelphia chromosome-positive chronic myeloid leukemia i... | [
"Small molecule drug"
] | Phase 3 Clinical | 1,635,465,600,000 | [
[
{
"name": "Philadelphia chromosome positive chronic myelogenous leukemia",
"lang": "EN"
},
{
"name": "费城染色体阳性慢性粒细胞白血病",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"United Kingdom",
"Canada",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "阿柏西普生物类似药 (安进)",
"lang": "CN"
},
{
"name": "Aflibercept-ayyh",
"lang": "EN"
}
] | [
{
"name": "Aflibercept Biosimilar (Amgen, Inc.)",
"lang": "EN"
},
{
"name": "阿柏西普生物类似药（Amgen, Inc.）",
"lang": "CN"
}
] | [
[
{
"name": "Placental Growth Factor",
"lang": "EN"
},
{
"name": "胎盘生长因子",
"lang": "CN"
}
],
[
{
"name": "Vascular endothelial growth factor A",
"lang": "EN"
},
{
"name": "血管内皮生长因子A",
"lang": "CN"
}
]
] | [
[
{
"name": "Diabetic macular oedema",
"lang": "EN"
},
{
"name": "糖尿病性黄斑水肿",
"lang": "CN"
}
],
[
{
"name": "Diabetic Retinopathy",
"lang": "EN"
},
{
"name": "糖尿病性视网膜病变",
"lang": "CN"
}
],
[
{
"name": "Retinal vein occl... | [
"Fc fusion protein",
"Biosimilar"
] | Approved | 1,724,371,200,000 | [
[
{
"name": "Diabetic macular oedema",
"lang": "EN"
},
{
"name": "糖尿病性黄斑水肿",
"lang": "CN"
}
],
[
{
"name": "Diabetic Retinopathy",
"lang": "EN"
},
{
"name": "糖尿病性视网膜病变",
"lang": "CN"
}
],
[
{
"name": "Retinal vein occl... | [
"United States",
"European Union",
"Canada",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "硫酸巴龙霉素",
"lang": "CN"
},
{
"name": "Paromomycin Sulfate",
"lang": "EN"
},
{
"name": "パロモマイシン硫酸塩",
"lang": "JP"
}
] | [
{
"name": "Aminosidin",
"lang": "EN"
},
{
"name": "Aminosidine",
"lang": "EN"
},
{
"name": "Aminosidine sulfate",
"lang": "EN"
},
{
"name": "Catenulin",
"lang": "EN"
},
{
"name": "Crestomycin",
"lang": "EN"
},
{
"name": "Estomycin",
"lang": "EN"
... | [
[
{
"name": "30S ribosomal subunit",
"lang": "EN"
},
{
"name": "30S核糖体亚基",
"lang": "CN"
}
]
] | [
[
{
"name": "Amebiasis",
"lang": "EN"
},
{
"name": "阿米巴病",
"lang": "CN"
}
],
[
{
"name": "Cryptosporidiosis",
"lang": "EN"
},
{
"name": "隐孢子虫病",
"lang": "CN"
}
],
[
{
"name": "Giardiasis",
"lang": "EN"
},
... | [
"Small molecule drug"
] | Preclinical | -347,155,200,000 | [
[
{
"name": "Cryptosporidiosis",
"lang": "EN"
},
{
"name": "隐孢子虫病",
"lang": "CN"
}
],
[
{
"name": "Giardiasis",
"lang": "EN"
},
{
"name": "贾第虫病",
"lang": "CN"
}
]
] | [
"United States",
"China",
"Japan"
] |
[
{
"name": "曲妥珠单抗生物类似药(CuraTeQ Biologics)",
"lang": "CN"
},
{
"name": "Trastuzumab biosimilar(CuraTeQ Biologics)",
"lang": "EN"
}
] | [
{
"name": "Trastuzumab Biosimilar (Aurobindo Pharma Ltd.)",
"lang": "EN"
},
{
"name": "曲妥珠单抗生物类似药（Aurobindo Pharma Ltd.）",
"lang": "CN"
}
] | [
[
{
"name": "Receptor tyrosine-protein kinase erbB-2",
"lang": "EN"
},
{
"name": "受体蛋白酪氨酸激酶 erbB-2",
"lang": "CN"
}
]
] | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
],
[
{
"name": "HER2-positive gastric cancer",
"lang": "EN"
},
{
"name": "HER2阳性胃癌",
"lang": "CN"
}
],
[
{
"name": "Early... | [
"Biosimilar",
"Monoclonal antibody"
] | Approved | 1,751,241,600,000 | [
[
{
"name": "Early Stage Breast Carcinoma",
"lang": "EN"
},
{
"name": "早期乳腺癌",
"lang": "CN"
}
],
[
{
"name": "HER2 positive Gastroesophageal Junction Adenocarcinoma",
"lang": "EN"
},
{
"name": "HER2阳性胃食管结合部腺癌",
"lang": "CN"
}
],
... | [
"European Union",
"United Kingdom",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "Desvenlafaxine Benzoate",
"lang": "EN"
}
] | null | [
[
{
"name": "Monoamine oxidase",
"lang": "EN"
},
{
"name": "单胺氧化酶家族",
"lang": "CN"
}
]
] | [
[
{
"name": "Depressive Disorder, Major",
"lang": "EN"
},
{
"name": "重度抑郁症",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,744,156,800,000 | [
[
{
"name": "Depressive Disorder, Major",
"lang": "EN"
},
{
"name": "重度抑郁症",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "盐酸纳呋拉啡",
"lang": "CN"
},
{
"name": "Nalfurafine Hydrochloride",
"lang": "EN"
},
{
"name": "ナルフラフィン塩酸塩",
"lang": "JP"
}
] | [
{
"name": "KORA",
"lang": "EN"
},
{
"name": "Nalfurafine",
"lang": "EN"
},
{
"name": "Nalfurafine hydrochloride (JAN/USAN)",
"lang": "EN"
},
{
"name": "Nopicor",
"lang": "EN"
},
{
"name": "Remitch OD",
"lang": "EN"
},
{
"name": "Winfuran",
"lang": ... | [
[
{
"name": "Kappa opioid receptor",
"lang": "EN"
},
{
"name": "κ-阿片受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Pruritus",
"lang": "EN"
},
{
"name": "瘙痒",
"lang": "CN"
}
],
[
{
"name": "Chronic liver disease",
"lang": "EN"
},
{
"name": "慢性肝病",
"lang": "CN"
}
],
[
{
"name": "Parkinson Disease",
"lang": "EN"
... | [
"Small molecule drug"
] | Discontinued | 1,232,496,000,000 | [
[
{
"name": "Pruritus",
"lang": "EN"
},
{
"name": "瘙痒",
"lang": "CN"
}
]
] | [
"China",
"Japan",
"South Korea"
] |
[
{
"name": "沙利度胺",
"lang": "CN"
},
{
"name": "Thalidomide",
"lang": "EN"
},
{
"name": "サリドマイド（JAN）",
"lang": "JP"
}
] | [
{
"name": "(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide",
"lang": "EN"
},
{
"name": "(+-)-Thalidomide",
"lang": "EN"
},
{
"name": "(±)-N-(2,6-dioxo-3-piperidyl)phthalimide",
"lang": "EN"
},
{
"name": "(±)-thalidomide",
"lang": "EN"
},
{
"name": "1,3-dioxo-2-(2,6-diox... | [
[
{
"name": "Tumor necrosis factor",
"lang": "EN"
},
{
"name": "肿瘤坏死因子",
"lang": "CN"
}
]
] | [
[
{
"name": "POEMS Syndrome",
"lang": "EN"
},
{
"name": "POEMS综合征",
"lang": "CN"
}
],
[
{
"name": "Leprosy, Lepromatous",
"lang": "EN"
},
{
"name": "麻风结节性红斑",
"lang": "CN"
}
],
[
{
"name": "Multiple Myeloma",
"la... | [
"Degradable Molecular Glue"
] | Discontinued | 900,547,200,000 | [
[
{
"name": "Erythema Nodosum",
"lang": "EN"
},
{
"name": "结节性红斑",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Australia",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "硫酸阿扎那韦",
"lang": "CN"
},
{
"name": "Atazanavir Sulfate",
"lang": "EN"
},
{
"name": "アタザナビル硫酸塩",
"lang": "JP"
}
] | [
{
"name": "ATZ",
"lang": "EN"
},
{
"name": "Atazanavir sulfate (JAN/USAN)",
"lang": "EN"
},
{
"name": "Atazor",
"lang": "EN"
},
{
"name": "TAZ",
"lang": "EN"
},
{
"name": "atazanavir sulphate",
"lang": "EN"
}
] | [
[
{
"name": "Human immunodeficiency virus type 1 protease",
"lang": "EN"
},
{
"name": "人类免疫缺陷病毒1型蛋白酶",
"lang": "CN"
}
]
] | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
],
[
{
"name": "Acquired Immunodeficiency Syndrome",
"lang": "EN"
},
{
"name": "获得性免疫缺陷综合征",
"lang": "CN"
}
],
[
{
"name": "Hyperlipidemia... | [
"Synthetic peptide"
] | Pending | 1,056,067,200,000 | [
[
{
"name": "HIV Infections",
"lang": "EN"
},
{
"name": "HIV感染",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "盐酸埃克替尼",
"lang": "CN"
},
{
"name": "Icotinib Hydrochloride",
"lang": "EN"
}
] | [
{
"name": "Conmana",
"lang": "EN"
},
{
"name": "Icotinib",
"lang": "EN"
},
{
"name": "埃克替尼",
"lang": "CN"
},
{
"name": "艾克替尼",
"lang": "CN"
}
] | [
[
{
"name": "EGFR exon 21 L858R mutation",
"lang": "EN"
},
{
"name": "EGFR21外显子L858R突变",
"lang": "CN"
}
]
] | [
[
{
"name": "Non-Small Cell Lung Cancer",
"lang": "EN"
},
{
"name": "非小细胞肺癌",
"lang": "CN"
}
],
[
{
"name": "EGFR-mutated non-small Cell Lung Cancer",
"lang": "EN"
},
{
"name": "EGFR突变的非小细胞肺癌",
"lang": "CN"
}
],
[
{
"n... | [
"Small molecule drug"
] | Suspended | 1,307,404,800,000 | [
[
{
"name": "Non-Small Cell Lung Cancer",
"lang": "EN"
},
{
"name": "非小细胞肺癌",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "对乙酰氨基酚/愈创甘油醚/无水咖啡因/DL-甲基麻黄碱盐酸盐/马来酸氯苯那敏",
"lang": "CN"
},
{
"name": "Acetaminophen/Guaifenesin/Anhydrous Caffeine/DL-Methylephedrine Hydrochloride/Chlorpheniramine Maleate",
"lang": "EN"
}
] | null | [
[
{
"name": "Adenosine A2a receptor",
"lang": "EN"
},
{
"name": "腺苷A2a受体",
"lang": "CN"
}
],
[
{
"name": "Adrenergic receptors",
"lang": "EN"
},
{
"name": "肾上腺素能受体家族",
"lang": "CN"
}
],
[
{
"name": "Histamine H1 recept... | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,768,953,600,000 | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "一酸化窒素",
"lang": "CN"
},
{
"name": "Nitric oxide (inhaled)",
"lang": "EN"
}
] | [
{
"name": "Inhaled nitric oxide (iNO)",
"lang": "EN"
},
{
"name": "LV UNO",
"lang": "EN"
},
{
"name": "Nitric Oxide Nasal Spray",
"lang": "EN"
},
{
"name": "UNO101",
"lang": "EN"
}
] | [
[
{
"name": "Hemoglobins",
"lang": "EN"
},
{
"name": "血红蛋白",
"lang": "CN"
}
]
] | [
[
{
"name": "Pulmonary Arterial Hypertension",
"lang": "EN"
},
{
"name": "肺动脉高压",
"lang": "CN"
}
],
[
{
"name": "COVID-19",
"lang": "EN"
},
{
"name": "新型冠状病毒感染",
"lang": "CN"
}
],
[
{
"name": "Hypoxic respiratory failu... | [
"Small molecule drug"
] | Pending | 945,907,200,000 | [
[
{
"name": "Respiratory Insufficiency",
"lang": "EN"
},
{
"name": "呼吸功能不全",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Australia",
"India",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "Centhaquine Citrate",
"lang": "EN"
}
] | [
{
"name": "Centhaquine",
"lang": "EN"
},
{
"name": "Centhaquine Citrate",
"lang": "EN"
}
] | [
[
{
"name": "Alpha-2a adrenergic receptor",
"lang": "EN"
},
{
"name": "肾上腺素能受体α-2a",
"lang": "CN"
}
],
[
{
"name": "Alpha-2b adrenergic receptor",
"lang": "EN"
},
{
"name": "肾上腺素能受体α-2b",
"lang": "CN"
}
]
] | [
[
{
"name": "Shock, Hemorrhagic",
"lang": "EN"
},
{
"name": "出血性休克",
"lang": "CN"
}
],
[
{
"name": "Respiratory Distress Syndrome, Acute",
"lang": "EN"
},
{
"name": "急性呼吸窘迫综合征",
"lang": "CN"
}
],
[
{
"name": "Hemorrhag... | [
"Small molecule drug"
] | Pending | 1,589,414,400,000 | [
[
{
"name": "Shock, Hemorrhagic",
"lang": "EN"
},
{
"name": "出血性休克",
"lang": "CN"
}
]
] | [
"India"
] |
[
{
"name": "达克珠单抗",
"lang": "CN"
},
{
"name": "Daclizumab",
"lang": "EN"
}
] | [
{
"name": "DAC HYP",
"lang": "EN"
},
{
"name": "Dacliximab",
"lang": "EN"
},
{
"name": "Daclizumab (USAN/INN)",
"lang": "EN"
},
{
"name": "Daclizumab HYP",
"lang": "EN"
},
{
"name": "Daclizumab beta",
"lang": "EN"
},
{
"name": "Daclizumab high-yield pr... | [
[
{
"name": "Interleukin-2 receptor alpha chain",
"lang": "EN"
},
{
"name": "白细胞介素-2受体α链",
"lang": "CN"
}
]
] | [
[
{
"name": "Multiple Sclerosis, Relapsing-Remitting",
"lang": "EN"
},
{
"name": "复发-缓解型多发性硬化",
"lang": "CN"
}
],
[
{
"name": "Multiple Sclerosis",
"lang": "EN"
},
{
"name": "多发性硬化症",
"lang": "CN"
}
],
[
{
"name": "Gra... | [
"Monoclonal antibody"
] | Discontinued | 881,712,000,000 | [
[
{
"name": "Graft Rejection",
"lang": "EN"
},
{
"name": "器官移植排斥",
"lang": "CN"
}
]
] | [
"United States",
"Canada"
] |
[
{
"name": "Regdanvimab",
"lang": "EN"
}
] | null | [
[
{
"name": "SARS-CoV-2 S protein",
"lang": "EN"
},
{
"name": "新冠病毒刺突蛋白",
"lang": "CN"
}
]
] | [
[
{
"name": "COVID-19",
"lang": "EN"
},
{
"name": "新型冠状病毒感染",
"lang": "CN"
}
],
[
{
"name": "Severe Acute Respiratory Syndrome",
"lang": "EN"
},
{
"name": "严重急性呼吸综合征",
"lang": "CN"
}
]
] | [
"Monoclonal antibody"
] | Approved | 1,612,483,200,000 | [
[
{
"name": "COVID-19",
"lang": "EN"
},
{
"name": "新型冠状病毒感染",
"lang": "CN"
}
]
] | [
"Australia",
"South Korea"
] |
[
{
"name": "特立帕肽生物类似药 (博康健基因)",
"lang": "CN"
},
{
"name": "Teriparatide Biosimilar(Genetech Pharmaceutical)",
"lang": "EN"
}
] | [
{
"name": "Teriparatide Biosimilar (Beijing Genetech Pharmaceutical Co. Ltd.)",
"lang": "EN"
},
{
"name": "特立帕肽生物类似药（Beijing Genetech Pharmaceutical Co. Ltd.）",
"lang": "CN"
}
] | [
[
{
"name": "Parathyroid hormone receptor",
"lang": "EN"
},
{
"name": "甲状旁腺激素受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Osteoporosis, Postmenopausal",
"lang": "EN"
},
{
"name": "绝经期后骨质疏松",
"lang": "CN"
}
],
[
{
"name": "Osteoporosis",
"lang": "EN"
},
{
"name": "骨质疏松症",
"lang": "CN"
}
]
] | [
"Recombinant polypeptide",
"Biosimilar",
"Peptide Hormone"
] | Approved | 1,705,363,200,000 | [
[
{
"name": "Osteoporosis, Postmenopausal",
"lang": "EN"
},
{
"name": "绝经期后骨质疏松",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "奥利组单抗",
"lang": "CN"
},
{
"name": "Ozoralizumab",
"lang": "EN"
},
{
"name": "オゾラリズマブ（遺伝子組換え）",
"lang": "JP"
}
] | [
{
"name": "Ozoralizumab (USAN)",
"lang": "EN"
},
{
"name": "Ozoralizumab (genetical recombination) (JAN)",
"lang": "EN"
},
{
"name": "anti-TNFα Nanobody",
"lang": "EN"
}
] | [
[
{
"name": "Tumor necrosis factor α",
"lang": "EN"
},
{
"name": "肿瘤坏死因子α",
"lang": "CN"
}
],
[
{
"name": "Serum albumin",
"lang": "EN"
},
{
"name": "血清白蛋白",
"lang": "CN"
}
]
] | [
[
{
"name": "Rheumatoid Arthritis",
"lang": "EN"
},
{
"name": "类风湿关节炎",
"lang": "CN"
}
],
[
{
"name": "Ankylosing Spondylitis",
"lang": "EN"
},
{
"name": "强直性脊柱炎",
"lang": "CN"
}
],
[
{
"name": "Crohn Disease",
"... | [
"Nanobody",
"Bispecific antibody"
] | Discontinued | 1,664,150,400,000 | [
[
{
"name": "Rheumatoid Arthritis",
"lang": "EN"
},
{
"name": "类风湿关节炎",
"lang": "CN"
}
]
] | [
"Japan"
] |
[
{
"name": "对乙酰氨基酚/马来酸氯苯那敏",
"lang": "CN"
},
{
"name": "Acetaminophen/Chlorpheniramine Maleate",
"lang": "EN"
}
] | null | [
[
{
"name": "Histamine H1 receptor",
"lang": "EN"
},
{
"name": "组胺H1受体",
"lang": "CN"
}
],
[
{
"name": "Cyclooxygenases",
"lang": "EN"
},
{
"name": "环氧化酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,770,595,200,000 | [
[
{
"name": "Common Cold",
"lang": "EN"
},
{
"name": "普通感冒",
"lang": "CN"
}
]
] | [
"South Korea"
] |
[
{
"name": "更昔洛韦",
"lang": "CN"
},
{
"name": "Ganciclovir",
"lang": "EN"
},
{
"name": "ガンシクロビル",
"lang": "JP"
}
] | [
{
"name": "2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol",
"lang": "EN"
},
{
"name": "2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one",
"lang": "EN"
},
{
"name": "2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one",
"lang": "EN"
},
{
... | [
[
{
"name": "DNA polymerase",
"lang": "EN"
},
{
"name": "DNA聚合酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Keratitis, Herpetic",
"lang": "EN"
},
{
"name": "疱疹性角膜炎",
"lang": "CN"
}
],
[
{
"name": "Cytomegalovirus Retinitis",
"lang": "EN"
},
{
"name": "巨细胞病毒视网膜炎",
"lang": "CN"
}
],
[
{
"name": "Cytomegalovirus In... | [
"Small molecule drug"
] | Pending | 614,563,200,000 | [
[
{
"name": "Cytomegalovirus Infections",
"lang": "EN"
},
{
"name": "巨细胞病毒感染",
"lang": "CN"
}
],
[
{
"name": "Cytomegalovirus Retinitis",
"lang": "EN"
},
{
"name": "巨细胞病毒视网膜炎",
"lang": "CN"
}
]
] | [
"United States",
"China",
"Japan",
"Canada",
"South Korea",
"Saudi Arabia"
] |
[
{
"name": "达雷妥尤单抗/重组人透明质酸酶PH20",
"lang": "CN"
},
{
"name": "Daratumumab/Hyaluronidase-fihj",
"lang": "EN"
},
{
"name": "ダラツムマブ（遺伝子組換え）/ボルヒアルロニダーゼ アルファ（遺伝子組換え）",
"lang": "JP"
}
] | [
{
"name": "DARA-SC",
"lang": "EN"
},
{
"name": "DARZALEX SC",
"lang": "EN"
},
{
"name": "DARZALEX-SC",
"lang": "EN"
},
{
"name": "Daratumumab Injection (Subcutaneous Injection)",
"lang": "EN"
},
{
"name": "Daratumumab subcutaneous",
"lang": "EN"
},
{
"... | [
[
{
"name": "Lymphocyte differentiation antigen CD38",
"lang": "EN"
},
{
"name": "淋巴细胞分化抗原CD38",
"lang": "CN"
}
],
[
{
"name": "Hyaluronic acid",
"lang": "EN"
},
{
"name": "透明质酸",
"lang": "CN"
}
]
] | [
[
{
"name": "Smoldering Multiple Myeloma",
"lang": "EN"
},
{
"name": "阴燃多发性骨髓瘤",
"lang": "CN"
}
],
[
{
"name": "Immunoglobulin Light-Chain Amyloidosis",
"lang": "EN"
},
{
"name": "免疫球蛋白轻链淀粉样变性",
"lang": "CN"
}
],
[
{
"... | [
"Monoclonal antibody",
"Enzyme"
] | Early Phase 1 | 1,500,249,600,000 | [
[
{
"name": "Refractory Multiple Myeloma",
"lang": "EN"
},
{
"name": "难治性多发性骨髓瘤",
"lang": "CN"
}
],
[
{
"name": "Relapse multiple myeloma",
"lang": "EN"
},
{
"name": "复发性多发性骨髓瘤",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Australia",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "伊匹木单抗N01",
"lang": "CN"
},
{
"name": "Ipilimumab N01",
"lang": "EN"
}
] | [
{
"name": "Anti-CTLA-4 antibody (Innovent Biologics)",
"lang": "EN"
},
{
"name": "Ipilimumab Biosimilar (Innovent Biologics (Suzhou) Co. Ltd.)",
"lang": "EN"
},
{
"name": "Ipilimumab biosimilar (Innovent Biologics)",
"lang": "EN"
},
{
"name": "伊匹木单抗生物类似药（信达生物）",
"lang": "... | [
[
{
"name": "Cytotoxic T-Lymphocyte-Associated Antigen 4",
"lang": "EN"
},
{
"name": "细胞毒性T淋巴细胞相关抗原4",
"lang": "CN"
}
]
] | [
[
{
"name": "Mismatch repair-deficient Colonic Cancer",
"lang": "EN"
},
{
"name": "错配修复缺陷或微高卫星不稳定性结肠癌",
"lang": "CN"
}
],
[
{
"name": "Advanced Hepatocellular Carcinoma",
"lang": "EN"
},
{
"name": "晚期肝细胞癌",
"lang": "CN"
}
],
[
... | [
"Biosimilar",
"Monoclonal antibody"
] | Discontinued | 1,766,361,600,000 | [
[
{
"name": "Mismatch repair-deficient Colonic Cancer",
"lang": "EN"
},
{
"name": "错配修复缺陷或微高卫星不稳定性结肠癌",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "地舒单抗生物类似药(Chemical Works of Gedeon Richter)",
"lang": "CN"
},
{
"name": "Denosumab Biosimilar(Chemical Works of Gedeon Richter)",
"lang": "EN"
}
] | [
{
"name": "Denosumab Biosimilar (Chemical Works of Gedeon Richter Plc)",
"lang": "EN"
},
{
"name": "地舒单抗生物类似药（Chemical Works of Gedeon Richter Plc）",
"lang": "CN"
}
] | [
[
{
"name": "Tumor necrosis factor ligand superfamily member 11",
"lang": "EN"
},
{
"name": "肿瘤坏死因子配体超家族成员11",
"lang": "CN"
}
]
] | [
[
{
"name": "Bone Cancer",
"lang": "EN"
},
{
"name": "骨癌",
"lang": "CN"
}
],
[
{
"name": "Giant Cell Tumor of Bone",
"lang": "EN"
},
{
"name": "骨巨细胞瘤",
"lang": "CN"
}
],
[
{
"name": "Glucocorticoid-induced osteoporosis... | [
"Biosimilar",
"Monoclonal antibody"
] | Approved | 1,750,636,800,000 | [
[
{
"name": "Bone Cancer",
"lang": "EN"
},
{
"name": "骨癌",
"lang": "CN"
}
],
[
{
"name": "Giant Cell Tumor of Bone",
"lang": "EN"
},
{
"name": "骨巨细胞瘤",
"lang": "CN"
}
],
[
{
"name": "Glucocorticoid-induced osteoporosis... | [
"United States",
"European Union",
"Iceland",
"South Korea",
"Liechtenstein",
"Norway"
] |
[
{
"name": "替雷利珠单抗",
"lang": "CN"
},
{
"name": "Tislelizumab",
"lang": "EN"
},
{
"name": "チスレリズマブ（遺伝子組換え）（JAN）",
"lang": "JP"
}
] | [
{
"name": "Tirelizumab",
"lang": "EN"
},
{
"name": "Tiselizumab",
"lang": "EN"
},
{
"name": "Tislelizumab (USAN/INN)",
"lang": "EN"
},
{
"name": "Tislelizumab-jsgr",
"lang": "EN"
},
{
"name": "替维布雷单抗",
"lang": "CN"
}
] | [
[
{
"name": "Programmed cell death protein 1",
"lang": "EN"
},
{
"name": "细胞程序性死亡-1",
"lang": "CN"
}
]
] | [
[
{
"name": "Esophageal Carcinoma",
"lang": "EN"
},
{
"name": "食管癌",
"lang": "CN"
}
],
[
{
"name": "PD-L1 positive Esophageal Squamous Cell Carcinoma",
"lang": "EN"
},
{
"name": "PD-L1阳性食管鳞状细胞癌",
"lang": "CN"
}
],
[
{
... | [
"Monoclonal antibody"
] | Phase 2 Clinical | 1,577,318,400,000 | [
[
{
"name": "Hodgkin's Lymphoma",
"lang": "EN"
},
{
"name": "霍奇金淋巴瘤",
"lang": "CN"
}
]
] | [
"United States",
"China",
"European Union",
"Japan",
"Canada",
"Australia",
"India",
"Israel",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "恒格列净/二甲双胍",
"lang": "CN"
},
{
"name": "Henagliflozein Proline/Metformin Hydrochloride",
"lang": "EN"
}
] | null | [
[
{
"name": "Protein kinase AMP-activated non-catalytic subunit beta 1",
"lang": "EN"
},
{
"name": "腺苷酸活化蛋白激酶亚基β1",
"lang": "CN"
}
],
[
{
"name": "Sodium/glucose cotransporter 2",
"lang": "EN"
},
{
"name": "钠-葡萄糖协同转运蛋白-2",
"lang": "CN"
... | [
[
{
"name": "Diabetes Mellitus, Type 2",
"lang": "EN"
},
{
"name": "2型糖尿病",
"lang": "CN"
}
]
] | [
"Small molecule drug"
] | Approved | 1,703,808,000,000 | [
[
{
"name": "Diabetes Mellitus, Type 2",
"lang": "EN"
},
{
"name": "2型糖尿病",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "培非格司亭生物类似药 (鲁南制药)",
"lang": "CN"
},
{
"name": "Pegfilgrastim biosimilar(Lunan Pharma)",
"lang": "EN"
}
] | [
{
"name": "Pegfilgrastim Biosimilar (Lunan Pharmaceutical Group Co., Ltd.)",
"lang": "EN"
},
{
"name": "Pegylated Human Granulocyte Colony-stimulating Factor (Lunan Pharma)",
"lang": "EN"
},
{
"name": "培非司亭生物类似药 (鲁南制药)",
"lang": "CN"
},
{
"name": "培非格司亭生物类似药（Lunan Pharmaceut... | [
[
{
"name": "Colony stimulating factor 3 receptor",
"lang": "EN"
},
{
"name": "巨噬细胞集落刺激因子3受体",
"lang": "CN"
}
]
] | [
[
{
"name": "Neutropenia",
"lang": "EN"
},
{
"name": "中性粒细胞减少",
"lang": "CN"
}
]
] | [
"Biosimilar",
"Colony-stimulating factors"
] | Approved | 1,619,740,800,000 | [
[
{
"name": "Neutropenia",
"lang": "EN"
},
{
"name": "中性粒细胞减少",
"lang": "CN"
}
]
] | [
"China"
] |
[
{
"name": "伊美司他",
"lang": "CN"
},
{
"name": "Imetelstat",
"lang": "EN"
}
] | [
{
"name": "Imetelstat (USAN/INN)",
"lang": "EN"
},
{
"name": "Imetelstat sodium",
"lang": "EN"
}
] | [
[
{
"name": "Telomerase",
"lang": "EN"
},
{
"name": "端粒末端转移酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Transfusion dependent anaemia",
"lang": "EN"
},
{
"name": "输血依赖性贫血",
"lang": "CN"
}
],
[
{
"name": "myelodysplastic anemia",
"lang": "EN"
},
{
"name": "骨髓增生异常性贫血",
"lang": "CN"
}
],
[
{
"name": "Myelodyspl... | [
"Oligonucleotide"
] | Phase 1 Clinical | 1,717,632,000,000 | [
[
{
"name": "myelodysplastic anemia",
"lang": "EN"
},
{
"name": "骨髓增生异常性贫血",
"lang": "CN"
}
]
] | [
"United States",
"European Union",
"Iceland",
"Liechtenstein",
"Norway"
] |
[
{
"name": "地尼白介素2",
"lang": "CN"
},
{
"name": "Denileukin Diftitox",
"lang": "EN"
},
{
"name": "デニロイキン ジフチトクス（遺伝子組換え）",
"lang": "JP"
}
] | [
{
"name": "DAB389 interleukin-2",
"lang": "EN"
},
{
"name": "Denileukin",
"lang": "EN"
},
{
"name": "Denileukin Diftitox (Genetical Recombination)",
"lang": "EN"
},
{
"name": "Denileukin Diftitox-cxdl",
"lang": "EN"
},
{
"name": "Denileukin difitox (genetical reco... | [
[
{
"name": "Interleukin-2 receptor alpha chain",
"lang": "EN"
},
{
"name": "白细胞介素-2受体α链",
"lang": "CN"
}
]
] | [
[
{
"name": "Cutaneous T-cell lymphoma refractory",
"lang": "EN"
},
{
"name": "皮肤难治性T细胞淋巴瘤",
"lang": "CN"
}
],
[
{
"name": "Recurrent cutaneous T-cell lymphoma",
"lang": "EN"
},
{
"name": "复发性皮肤T细胞淋巴瘤",
"lang": "CN"
}
],
[
{... | [
"Fusion protein"
] | Clinical | 918,172,800,000 | [
[
{
"name": "Cutaneous T-Cell Lymphoma",
"lang": "EN"
},
{
"name": "皮肤T细胞淋巴瘤",
"lang": "CN"
}
]
] | [
"United States",
"Japan"
] |
[
{
"name": "曲妥珠单抗生物类似药 (上海复宏汉霖生物)",
"lang": "CN"
},
{
"name": "Trastuzumab biosimilar(Shanghai Henlius Biotech, Inc.)",
"lang": "EN"
}
] | [
{
"name": "TRASTUZUMAB-STRF",
"lang": "EN"
},
{
"name": "Trastuzumab Biosimilar (Shanghai Henlius Biotech, Inc.)",
"lang": "EN"
},
{
"name": "曲妥珠单抗生物类似药（Shanghai Henlius Biotech, Inc.）",
"lang": "CN"
}
] | [
[
{
"name": "Receptor tyrosine-protein kinase erbB-2",
"lang": "EN"
},
{
"name": "受体蛋白酪氨酸激酶 erbB-2",
"lang": "CN"
}
]
] | [
[
{
"name": "Early Stage Breast Carcinoma",
"lang": "EN"
},
{
"name": "早期乳腺癌",
"lang": "CN"
}
],
[
{
"name": "Metastatic breast cancer",
"lang": "EN"
},
{
"name": "转移性乳腺癌",
"lang": "CN"
}
],
[
{
"name": "HER2 positive ... | [
"Biosimilar",
"Monoclonal antibody"
] | Approved | 1,595,808,000,000 | [
[
{
"name": "HER2 Positive Breast Cancer",
"lang": "EN"
},
{
"name": "HER2阳性乳腺癌",
"lang": "CN"
}
],
[
{
"name": "HER2 positive Gastroesophageal Junction Adenocarcinoma",
"lang": "EN"
},
{
"name": "HER2阳性胃食管结合部腺癌",
"lang": "CN"
}
]... | [
"United States",
"China",
"European Union",
"Canada",
"Australia",
"Iceland",
"Liechtenstein",
"Norway",
"Philippines",
"Thailand"
] |
[
{
"name": "雷替曲塞",
"lang": "CN"
},
{
"name": "Raltitrexed",
"lang": "EN"
}
] | [
{
"name": "Raltitrexed (JAN/USAN/INN)",
"lang": "EN"
}
] | [
[
{
"name": "Thymidylate synthase",
"lang": "EN"
},
{
"name": "胸苷酸合成酶",
"lang": "CN"
}
]
] | [
[
{
"name": "Colorectal Cancer",
"lang": "EN"
},
{
"name": "结直肠癌",
"lang": "CN"
}
],
[
{
"name": "Hepatocellular Carcinoma",
"lang": "EN"
},
{
"name": "肝细胞癌",
"lang": "CN"
}
],
[
{
"name": "Primary Malignant Liver Neop... | [
"Small molecule drug"
] | Early Phase 1 | 837,388,800,000 | [
[
{
"name": "Colorectal Cancer",
"lang": "EN"
},
{
"name": "结直肠癌",
"lang": "CN"
}
]
] | [
"China",
"Canada",
"Australia",
"Switzerland"
] |
[
{
"name": "贝伐珠单抗生物类似药(Outlook Therapeutics)",
"lang": "CN"
},
{
"name": "Bevacizumab biosimilar(Outlook Therapeutics)",
"lang": "EN"
}
] | [
{
"name": "Bevacizumab Biosimilar (Outlook Therapeutics, Inc.)",
"lang": "EN"
},
{
"name": "Bevacizumab gamma(Outlook Therapeutics)",
"lang": "EN"
},
{
"name": "Bevacizumab-vikg(Outlook Therapeutics)",
"lang": "EN"
},
{
"name": "贝伐珠单抗生物类似药（Outlook Therapeutics, Inc.）",
"l... | [
[
{
"name": "Vascular endothelial growth factor A",
"lang": "EN"
},
{
"name": "血管内皮生长因子A",
"lang": "CN"
}
]
] | [
[
{
"name": "Wet age-related macular degeneration",
"lang": "EN"
},
{
"name": "湿性年龄相关性黄斑变性",
"lang": "CN"
}
],
[
{
"name": "Diabetic macular oedema",
"lang": "EN"
},
{
"name": "糖尿病性黄斑水肿",
"lang": "CN"
}
],
[
{
"name": ... | [
"Biosimilar",
"Monoclonal antibody"
] | Phase 1 Clinical | 1,716,768,000,000 | [
[
{
"name": "Wet age-related macular degeneration",
"lang": "EN"
},
{
"name": "湿性年龄相关性黄斑变性",
"lang": "CN"
}
]
] | [
"European Union",
"United Kingdom",
"Iceland",
"Liechtenstein",
"Norway"
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.